Next Article in Journal
The Exometabolome of Xylella fastidiosa in Contact with Paraburkholderia phytofirmans Supernatant Reveals Changes in Nicotinamide, Amino Acids, Biotin, and Plant Hormones
Previous Article in Journal
Optimized Mass Spectrometry Detection of Thyroid Hormones and Polar Metabolites in Rodent Cerebrospinal Fluid
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

A Review of the Ethnobotanical Use, Chemistry and Pharmacological Activities of Constituents Derived from the Plant Genus Geijera (Rutaceae)

by
Deepika Dugan
1,
Rachael J. Bell
1,
Robert Brkljača
2,
Colin Rix
1 and
Sylvia Urban
1,*
1
Marine and Terrestrial Natural Product (MATNAP) Research Group, School of Science (Applied Chemistry and Environmental Science), RMIT University, GPO Box 2476, Melbourne, VIC 3001, Australia
2
Monash Biomedical Imaging, Monash University, Clayton, VIC 3168, Australia
*
Author to whom correspondence should be addressed.
Metabolites 2024, 14(2), 81; https://doi.org/10.3390/metabo14020081
Submission received: 21 December 2023 / Revised: 16 January 2024 / Accepted: 17 January 2024 / Published: 23 January 2024
(This article belongs to the Section Thematic Reviews)

Abstract

:
Geijera Schott is a plant genus of the Rutaceae Juss. (rue and citrus) family, comprising six species which are all native to Oceania. Of the plants belonging to this genus, the most significant species that has a customary use is Geijera parviflora, which was used by Indigenous Australians, primarily as a pain reliever. Herein, a comprehensive review of the literature published on the genus Geijera from 1930 to 2023 was conducted. This is the first review for this plant genus, and it highlights the chemical constituents reported to date, together with the range of pharmacological properties described from the various species and different parts of the plant. These properties include anti-inflammatory, anti-microbial, anti-parasitic, insect repellent, analgesic, neuroactive, and anti-cancer activities. Finally, a reflection on some of the important areas for future focused studies of this plant genus is provided.

Graphical Abstract

1. Introduction

The genus Geijera contains six accepted species that are native to Australia, New Guinea, and New Caledonia [1]. Although the International Plant Names Index has over twenty species names listed in association with this genus, a large proportion of these are either synonyms of the accepted species or names that have been superseded due to taxonomic reclassification. The six species of the genus are listed below in Table 1 [2,3]. The species of this genus are found in rainforests, dry rainforests, woodlands, dry scrub, and open inland areas [4].
To date, phytochemical investigations have only been conducted on four of the six Geijera species. The chemical constituents provided in this review are, therefore, limited to the studies conducted on Geijera parviflora Lindl., Geijera linearifolia (DC.) J.M. Black (both endemic to Australia), Geijera salicifolia Schott (endemic to Australia, Papua New Guinea, and New Caledonia) and Geijera balansae (Baill.) Schinz & Guillaumin (endemic to New Caledonia). No phytochemical information is available for Geijera cauliflora Baill., and Geijera tartarea T.G. Hartley ex Munzinger & Bruy, which are both endemic to New Caledonia. Phytochemical investigation of the latter two species has been neglected possibly due to their rarity, their inaccessibility, or that they occur in a remote location. Geijera tartarea is a newly described, rare, and endangered species [5]. The 117 reported compounds in this review have been grouped on the basis of their chemical class and are numbered sequentially in Table 2, Table 3, Table 4 and Table 5.
The flowering plants of most endemic Rutaceae species in Oceania occur as low scleromorphic shrubs, whereas all species of Geijera can be described as large sclerophyllous shrubs [6]. Figure 1 illustrates the geographical distribution of Geijera species in Oceania.
The customary use of plants has been occurring for at least 65,000 years by the Indigenous Australians [7]. Interest in the chemical constituents of the Geijera species, particularly G. parviflora, has been motivated by the customary use of this plant in Australian bush medicine. Commonly known as dogwood or wilga (‘Wilgarr’ in the Wiradjuri language, ‘Nhiitaka’ or ‘Katha’ in Paakantyi (Barkindji), ‘Puri’ or ‘Buri’ in Mutthi Mutthi and ‘Dhiil’ or ‘Dheal’ in the Gamilarray, Yuwaalaray and Yuwaalayaay language groups), G. parviflora is considered a sacred tree and is of cultural importance to the Indigenous people of Australia, especially during burials and ceremonies [8]. It is a hardy, long-lived species that grows about 8 m tall with a wide, dense canopy and it can live for over 100 years.
The leaves of G. parviflora were used to prepare a ceremonial smoke together with leaves from other trees such as ‘Badha’ or ‘Budda’ Native Sandalwood, Eremophila mitchellii Benth., ‘Coolabah’ Eucalyptus coolabah Blakely & Jacobs and ‘Gurraay’ White Cypress Pine Callitris columellaris F.Muell. [8]. G. parviflora leaves were also used in ceremonies where they were baked, powdered, and smoked with other plant materials to induce intoxication and drowsiness, akin to the effects of alcohol [9]. The leaves were also chewed or placed into dental cavities for the relief of toothache or crushed and used as an external pain reliever [10]. An infusion of the leaves was used both internally and externally to relieve pain [11,12]. Leaf infusions were also used for bathing to provide skin care and to relieve sore muscles; they were used cold for sore eyes and ears, and apart from this, they were drunk to cure blood disorders [13]. The hot leaves were used as a poultice on sores and boils, and the bark was steeped in water for use as a laxative [13]. The leaves were also burned around camp sites as an insect repellent and the wood was used for spears and boomerangs [13]. Apart from these uses, the tree was valued as a source of pollen and nectar for honey production, the fruits and flowers of G. parviflora were eaten, and its aromatic leaves were used during cooking as a flavoring for emu meat [14,15].
G. parviflora is the most extensively studied species of the genus Geijera and it exhibits considerable variability in the composition of its essential oils and other chemical constituents, such as its coumarins [16]. During an initial investigation by Penfold in 1930, he noted that morphologically indistinguishable specimens had different chemotypes based on the character of their leaf essential oils [17,18,19]. The leaves of G. parviflora were observed to exhibit selective palatability as fodder for sheep, wherein certain plants would be readily consumed by stock whilst others would not. Two coumarins, dehydrogeijerin 13 and geiparvarin 2 (Table 2), were later isolated by Lahey and Macleod from specimens deemed either ‘unpalatable’ or ‘readily eaten’ [20]. It was found that 13 was only present in the unpalatable variety, and that 2 was only in the readily eaten variety. It was also observed that the readily eaten variety ‘Tree wilga’, occurred in drier areas, while the variety deemed unpalatable, ‘Lavender bush’ occurred in areas with greater than 500 mm of rainfall per annum [16]. The connection that was drawn between the two different coumarins present in the specimens and their palatability to sheep has not been validated [21]. After further research conducted by Brophy and Goldsack [16], G. parviflora now has four established chemotypes, based upon differing compositions of the leaf essential oils of the plant, with another four possible chemotypes having been tentatively identified by Sadgrove et al. [16,22].
G. salicifolia (scrub wilga, greenheart, green satinheart) is a long-lived, drought-tolerant and hardy species, utilised mainly for its timber, which was used to make fishing rods and cabinetry [23]. Its wood was traditionally used for making implements, weapons, and jewellery [24]. According to the Dharawal pharmacopeia collection recorded by Auntie Frances Bodkin, a Dharawal elder, G. salicifolia is also commonly called wilga and (similarly to G. parviflora) its leaves have customary use by the Dharawal people for pain relief, whereby they are chewed to alleviate toothache [24]. The vapors from the hot leaves are also used to relieve headache [24]. Two chemotypes of this species have been identified based upon differing composition of its leaf essential oils [16].
Uses of the other species from the Geijera genus for medicinal or other purposes (apart from timber) have not been recorded.
The purpose of this study was to review the chemical constituents within the genus Geijera Schott as reported up to December 2023, this being the first such review on the genus. Geijera is a genus that belongs to the family Rutaceae Juss. (rue and citrus family), which contains about 2100 species in 154 genera [25]. Apart from providing important nutritional benefits, many members of the Rutaceae are valuable sources of bioactive compounds such as alkaloids, coumarins (notably furano- and pyrano-coumarins), volatile oils, flavonoids, and limonoids [26]. This review provides a detailed account of the chemical constituents reported from the Geijera genus to date. However, it is only representative of four of the six Geijera species, as no studies have been reported for the chemical constituents of G. cauliflora and G. tartarea. In addition to the description of the constituents isolated from Geijera, their reported pharmacological activities are also summarised. Although a detailed treatment of the various specific pharmacological activities reported from these compounds is beyond the scope of this review, a concise summary has been provided. Specifically, the pharmacological activities relevant to the traditional use of G. parviflora are summarised to aid identification of constituents, which might be responsible for the customary medicinal uses of G. parviflora in Australian bush medicine. Constituents with notable properties such as anti-cancer activity are also included. Subsequent database searching of the relevant chemical constituents provided an account of what main types of pharmacological activities have been reported in the literature. Therefore, the documented pharmacological activities in this review are not necessarily reported from within the same publications that identified the chemical constituents in the Geijera plant species.

2. Methodology

The scientific literature published on the genus Geijera from 1930 to 2023 has been reviewed with a particular focus on publications pertaining to the phytochemicals that are specific to this genus. The databases employed for compiling this review included Google, Google Scholar, ScienceDirect (147 results), SciFindern (50 results), Scopus (44 results), Springer Link (78 results), PubMed (12 results), Wiley (124 results), and the Web of Science (43 results). Within the results, there were approximately 20 publications specifically reporting the isolation of chemical constituents from this plant genus. The search terms or keywords included Geijera, Geijera parviflora, Geijera salicifolia, Geijera linearifolia, Geijera balansae, Geijera cauliflora, Geijera tartarea, and wilga.

3. Chemical Constituents in Geijera Species

A total of 117 plant compounds have been identified via phytochemical investigations of four plant species of the Geijera genus, covering G. balansae, G. linearifolia, G. parviflora, and G. salicifolia. The compounds can be generally assigned to the following classes: coumarins, alkaloids, phenolic compounds, a flavonoid, fatty alcohol esters, fatty acid esters, phenylpropanoids, terpenes and terpenoids, and these appear sequentially in Table 2, Table 3, Table 4 and Table 5.
Most of the compounds identified from the genus Geijera originate from G. parviflora, which has been studied more than the other species, mainly due to its traditional medicinal uses by Indigenous cultures, as well as its utility as stock fodder during times of drought in the early- to mid-20th century. As shown in Figure 2, the other Geijera species have had little study in comparison. Hence, there is clear potential for further compound identification and discovery, especially considering the various bioactivities displayed by the chemical constituents identified to date. It also shows that while 117 compounds have been identified among the four species, many of these occur across multiple species of Geijera.
The number of chemical constituents according to the compound classes identified from the four Geijera species studied is illustrated in Figure 3, showing that the terpenes represent by far the most frequently isolated compound class across these species. It also shows that G. balansae is the only species to not have any terpenes reported. Terpenes are dominant components in the plant kingdom, so it is unlikely that G. balansae does not contain terpenes, but rather is indicative that no terpenes have yet been reported because the extraction methods employed to study this species to date have specifically targeted the isolation of alkaloids [27,28]. Similarly with G. linearifolia, only terpenes have been reported; however, this does not suggest only terpene-like compounds are being produced by G. linearifolia, but that further study of G. linearifolia is needed to reveal additional compound classes present.
Investigations on the other three Geijera species have focused on the plant essential oils which were obtained via hydro-distillation, as well as other targeted extraction methods employed for the extraction of coumarins and alkaloids. Studies on G. linearifolia reported the presence of terpenes, but not any other compound classes because only the volatile component/essential oil from this species has been studied [16].
As a result of conducting this review, it became evident that more than 60% of the compounds that have been reported from this plant genus require further verification and validation using spectroscopic techniques and other isolation strategies. Several compounds (largely terpenes and terpenoids) were identified solely based on GC-MS retention times, molecular weights, and database comparison, which can be inadequate for the elucidation of geometric/structural/stereoisomeric structures. The formation of artefacts that can result from isolation procedures, where plant materials are subjected to thermal treatment during hydro-distillation and gas chromatography, is another consideration to bear in mind. An example of this is the sesquiterpene geijerene 70, which is accepted to be a thermal Cope rearrangement product that is formed from its precursor, pregeijerene 68, which is a major constituent of the essential oil of one G. parviflora chemotype [22,29].
Despite considerations like the ones stated above, most of the reported compounds have been included in this review due to the variety of pharmacological properties that they possess. Minor constituents present in less than 1% of the essential oils, as well as constituents of aged plant essential oils that have been reported via GC-MS analysis, were omitted from the review. The rationale for this was due to their insignificant quantity and/or high likelihood of them being artefacts formed by processes such as oxidation and polymerisation as the oils age over several months or years. An interesting comparison of the character of aged essential oils with fresh samples that was performed by Sadgrove et al., demonstrated that the antimicrobial activity of aged samples increased compared to that of the fresh samples [9].

3.1. Coumarins

Coumarins are common in the Rutaceae plant family, and they primarily act as phytoalexins and allelochemicals. Their physiological roles are diverse and include protection of the plant against traumatic injury, microorganism infection by inhibition of the growth of bacteria and fungi, facilitating iron uptake from soil, as well as providing protection by repelling herbivorous insects [30]. The Rutaceae produce a range of pyrano-, furano- and prenylated-coumarins, in addition to the simple coumarins, all of which frequently display potent pharmacological effects [31]. The activity of coumarins is often attributed to the reactivity of the benzofuran system in their molecular structure; however, many simple coumarins also possess potent activity, e.g., the toxicity of umbelliferone 1 (Table 2) against insect herbivores and rodents [31,32,33,34]. Amongst other functions, 1 is a key intermediate in prenylcoumarin biosynthesis, which gives rise to the furanocoumarins and pyranocoumarins such as angelicin (isopsoralen) 16 and xanthyletine 17 [35].
Within Geijera, coumarins have been identified in the leaves of G. balansae, G. parviflora and G. salicifolia as well as the bark of G. balansae. Nineteen coumarins have been reported from the genus, consisting of nine monosubstituted coumarins 1–9 including umbelliferone 1, and six disubstituted coumarins 10–15, furanocoumarin angelicin (isopsoralen) 16, and three pyranocoumarins 17–19. Compounds 11, 12, and 15–17 were identified by Sadgrove et al. in trace amounts, based on GC-MS analysis of extracts. The unequivocal identification of these five coumarins within G. parviflora requires further investigation using targeted extraction strategies, in conjunction with the application of spectroscopic techniques for structure identification/elucidation. Luvangentin 18 was isolated from the leaves and xanthoxyletin 19 was isolated from the bark of the New Caledonian species G. balansae by Mitaku et al. (Table 2).
The coumarins geiparvarin 2 and dehydrogeijerin 13 were isolated by Lahey and Macleod from G. parviflora specimens deemed either ‘readily eaten’ or ‘unpalatable’. It was found that 13 was only present in leaves of the unpalatable variety which occurs in wetter areas, and that 2 was only present in leaves of the readily eaten variety, which occurs in drier areas [16]. Further work is needed to establish the validity of the connection between the palatability of these two chemotypes and the coumarins present therein.
Geiparvarin 2 has been found only in G. parviflora and G. salicifolia, and being a major constituent of leaf extracts, it has been identified as one of the main contributors to the pharmacological activities of these plants [36]. Its derivatives, such as 2′,3′-dihydrogeiparvarin 6, parvifloranine A 8, parvifloranine B 9, and 6-(methoxyl) geiparvarin 14, have only been found in G. parviflora so far. This coumarin and its derivatives can be said to be chemotaxonomic markers for the two abovementioned Geijera species, although more phytochemical investigation is required to establish whether they are also present in the other species of the genus or elsewhere within other taxa.
Table 2. Coumarins identified within the genus Geijera.
Table 2. Coumarins identified within the genus Geijera.
Compound and Exact Mass (Da)SourceMethod of IdentificationReferencePharmacological Activity of Compound (Various Sources)
1
umbelliferone
G. salicifolia (leaves)Melting point, IR and 1H NMR[37]Anti-inflammatory, antinociceptive, anti-hyperglycaemic, antibacterial, antifungal, inhibition of DPPH, hydroxyl, superoxide anion and ABTS radicals, molluscicide, antifeedant, anti-tumour, antimutagenic, fluorescent (sunscreen agent), bone-protective, anti-biofilm [38,39,40]
Metabolites 14 00081 i001
162.0317
2
geiparvarin
G. parviflora (leaves)Combustion analysis, chemical derivatisation, UV, IR (G.p)[20,37]Anti-cancer, monoamine oxidase B inhibitor [41,42,43]
Metabolites 14 00081 i002
326.1154G. salicifolia (leaves)IR and 1H NMR (G.s)
3
auraptene
G. parviflora (fruit/seeds)IR and 1H NMR[44]Increases collagen I expression, anti-bacterial, anti-fungal, antileishmanial, anti-cancer, and antioxidant [45,46]
Metabolites 14 00081 i003
298.1569
4
marmin
G. parviflora (fruit/seeds)IR and 1H NMR[44]No significant anti-inflammatory activity [47]
Metabolites 14 00081 i004
332.1624
5
6′-dehydromarmin
G. parviflora (fruit/seeds)IR and 1H NMR[44]Anti-inflammatory, cytotoxic [10]
Metabolites 14 00081 i005
330.1467
6
2′,3′-dihydrogeiparvarin
G. parviflora (fruit/seeds)IR and 1H NMR[44,48]Anti-cancer [48,49]
Metabolites 14 00081 i006G. salicifolia (leaves)
330.1467
7
(R)-6-O-(4-geranyloxy-2-hydroxy)
cinnamoylmarmin
G. parviflora
(leaves)
2D NMR[10]Cytotoxic, anti-inflammatory [10]
Metabolites 14 00081 i007
630.3193
8
parvifloranine A
G. parviflora (leaves)2D NMR, ECD and MS[50]Anti-inflammatory [50]
Metabolites 14 00081 i008
453.1788
9
parvifloranine B
G. parviflora (leaves)2D NMR, ECD and MS[50]No significant anti-inflammatory activity [50]
Metabolites 14 00081 i009
470.1689
10
geijerin
G. salicifolia (bark)Chemical derivatisation, UV, and IR[37,51]Acetylcholinesterase inhibitor [52]
Metabolites 14 00081 i010G. parviflora
(leaves)
Melting point, IR and 1H NMR
260.1049
11
scoparone
G. parviflora (leaves)GC-MS[21]Antifungal, anti-inflammatory, antioxidant, anti-apoptotic, anti-fibrotic, and hypolipidemic [53,54]
Metabolites 14 00081 i011
206.0579
12
suberosin
G. parviflora (leaves)GC-MS[21]Anti-inflammatory and anticoagulant [55,56]
Metabolites 14 00081 i012
244.1099
13
dehydrogeijerin
G. parviflora (leaves)Chemical derivatisation, UV, and IR (G.p)[20,37]Anti-inflammatory activity, acetylcholinesterase inhibitor [52,57]
Metabolites 14 00081 i013G. salicifolia (leaves)IR and 1H NMR (G.s)
258.0892
14
6-(methoxyl) geiparvarin
G. parviflora (leaves)13C and 1H NMR [10]Anti-inflammatory, cytotoxic [10]
Metabolites 14 00081 i014
356.1260
15
osthole
G. parviflora (leaves)GC-MS[22]Antitumour, anti-inflammatory, neuroprotective, anxiolytic, osteogenic, cardiovascular protective, antimicrobial, antiparasitic [58,59]
Metabolites 14 00081 i015
244.1099
16
angelicin (isopsoralen)
G. parviflora (leaves)GC-MS[22]Anti-cancer, pro-osteogenic, antiviral, pro-chondrogenic, anti-inflammatory, erythroid differentiating, anti-periodontitis [60,61]
Metabolites 14 00081 i016
186.0317
17
xanthyletine
G. parviflora (leaves)GC-MS[22]Antimicrobial, fungicide [62,63]
Metabolites 14 00081 i017
228.0786
18
luvangetin
G. balansae
(leaves)
UV, IR, 1H NMR, MS[28]Antiulcer, antifungal, anti-inflammatory, antibacterial [64,65]
Metabolites 14 00081 i018
258.0892
19
xanthoxyletin
G. balansae
(bark)
UV, IR, 1H NMR, MS[28]Anticonvulsant, anti-inflammatory, carbonic anhydrase inhibitor, anti-malaria, histone lysine methyltransferase G9a inhibitor [66,67]
Metabolites 14 00081 i019
258.0892
(Key: G.pG. parviflora, G.sG. salicifolia).

3.2. Alkaloids

The isolation of twenty-two alkaloids has been reported from the genus Geijera, which includes five anthranilic acid derivatives, sixteen quinolones/quinolines (also derived from anthranilic acid), and a phenylethylamine-derived proto alkaloid hordenine. The five anthranilic acid derivatives 20–24 were isolated from the leaves of G. parviflora [68]. Three furoquinolines 25–27 [28,69], two isopropyldihydrofuroquinolines 28–29 [28,69], eight quinolones 30–37 [10,28,44], two dihydropyranoquinolines, 38–39 [27] and one dimeric quinolone 40 [28] have been isolated from the leaves, bark, and wood of species of Geijera. The quinolone flindersine 30 was isolated from the seeds/fruits of G. parviflora as well as from the leaves of G. balansae [28,44]. Additionally, hordenine 41 was isolated from the leaves of G. balansae [28] (Table 3).
Anthranilic acid derivatives are widely distributed within the Rutaceae family, but are of restricted distribution outside of this plant family [70]. The known physiological roles of alkaloids are generally accepted as providing protection for plants from pathogens and predators through their toxicity, as well as being involved in cell signalling and regulation of plant growth [71]. Alkaloids of genus Geijera display antimicrobial (including some against drug-resistant strains), anti-inflammatory, and other specific pharmacological activities as summarised in Table 3. Alkaloids, such as flindersine 30 and its derivatives, display significant activity in the mediation of inflammation, and these properties could help to explain the customary use of G. parviflora [10]. The dimeric quinolone alkaloid geijedimerine 40 from the leaves of G. balansae is unique to this species and has not been found so far in other taxa.
Table 3. Alkaloids identified within the genus Geijera.
Table 3. Alkaloids identified within the genus Geijera.
Compound and Exact Mass (Da)SourceMethod of
Identification
ReferencePharmacological Activity of Compound (Various Sources)
20
11′-hexadecenoyl anthranilic acid
G. parviflora (leaves)HRESI-MS, IR, UV, 13C and 1H NMR[68]Antibacterial vs. Gram positive bacteria [68]
Metabolites 14 00081 i020
373.2617
21
9′-hexadecenoyl anthranilic acid
G. parviflora (leaves)HRESI-MS, IR, UV, 13C and 1H NMR[68]Antibacterial vs. Gram positive bacteria [68]
Metabolites 14 00081 i021
373.2617
22
7′-hexadecenoyl anthranilic acid
G. parviflora (leaves)HRESI-MS, IR, UV, 13C and 1H NMR[68]Antibacterial vs. Gram positive bacteria [68]
Metabolites 14 00081 i022
373.2617
23
9,12,15-octadecatrienoyl anthranilic acid
G. parviflora (leaves)HRESI-MS, IR, UV, 13C and 1H NMR[68]Did not display significant antibacterial activity [68]
Metabolites 14 00081 i023
383.2460
24
hexadecanoyl anthranilic acid
G. parviflora (leaves)HRESI-MS, IR, UV, 13C and 1H NMR[68]Antibacterial vs. Gram positive bacteria [68]
Metabolites 14 00081 i024
375.2773
25
dictamnine
G. balansae (wood/bark)1H NMR, IR, UV, and MS[28]Antibacterial, antiviral, antifungal, antiprotozoal, anti-cancer, anti-inflammatory, antioxidant, cardiovascular, antiplatelet, antiosteoporosis, anti-anaphylactoid [72]
Metabolites 14 00081 i025
199.0633
26
skimmianine
G. salicifolia (leaves)IR, melting point (G.s)[28,69]Anti-inflammatory, acetylcholinesterase inhibitor, anti-cancer [73,74,75]
Metabolites 14 00081 i026G. balansae (wood/bark)1H NMR, IR, UV, and MS (G.b)
259.0845
27
γ-fagarine
G. salicifolia (leaves)IR, melting point (G.s)[28,69]Antileishmanial [76]
Metabolites 14 00081 i027G. balansae (wood/bark)1H NMR, IR, UV, and MS (G.b)
229.0739
28
platydesmine
G. salicifolia (leaves)Melting point, combustion analysis, chemical degradation, IR, UV and 1H NMR (G.s)[28,69]Antifungal [77]
Metabolites 14 00081 i028
259.1208G. balansae (leaves)1H NMR, IR, UV, and MS (G.b)
29
platydesmine acetate
G. salicifolia (leaves)Combustion analysis, chemical degradation, IR and 1H NMR[69]No activity reported to date
Metabolites 14 00081 i029
301.1314
30
flindersine
G. parviflora (fruit/seeds) IR and melting point (G.p)[28,44]Anti-inflammatory, collagen III suppression, antibacterial, antifungal [10,45,78]
Metabolites 14 00081 i030G. balansae (leaves)1H NMR, IR, UV, and MS (G.b)
227.0946
31
4′-hydroxy-3′,4′-dihydroflindersine
G. balansae (leaves)Chemical synthesis/derivatisation, 1H NMR, IR, UV, and MS[28]No activity reported to date
Metabolites 14 00081 i031
245.1052
32
cis-3′,4′-dihydroxy-3′,4′-dihydroflindersine
G. balansae (leaves)Chemical synthesis/derivatisation, 1H NMR, IR, UV, and MS[28]No activity reported to date
Metabolites 14 00081 i032
261.1001
33
zanthobungeanine
G. balansae (leaves)1H NMR, IR, UV, and MS[28]Leishmanicidal activity on Leishmania Viannia panamensis intracellular amastigotes (EC50: 8.7 µg/)mL and promastigotes (EC50: 14.3 µg/)mL, respectively [79]
Metabolites 14 00081 i033
271.1208
34
8-(methoxyl)-flindersine
G. parviflora (leaves)UV, IR, 2D NMR and MS[10]No activity reported to date
Metabolites 14 00081 i034
257.1052
35
N-(acetoxymethyl) flindersine
G. parviflora (leaves)UV, IR, 2D NMR and MS[10]Anti-inflammatory, collagen III suppression [10,45]
Metabolites 14 00081 i035
299.1158
36
haplaphine
G. parviflora (leaves)UV, IR, 2D NMR and MS (G.p)[10,28]Anti-inflammatory, cytotoxic [10]
Metabolites 14 00081 i036G. balansae (bark)1H NMR, IR, UV, and MS (G.b)
229.1103
37
4-methoxy N-methyl-2-quinolone
G. balansae (bark)1H NMR, IR, UV, and MS[28]Antimicrobial against MRSA, IC50 8.0 µM [80]
Metabolites 14 00081 i037
189.0790
38
geibalansine
G. balansae (leaves)Chemical synthesis/derivatisation, 1H NMR, IR, UV, and MS[27]Antispasmodic [81]
Metabolites 14 00081 i038
259.1208
39
O-acetyl geibalansine
G. balansae (leaves)Chemical derivatisation, 1H NMR, IR, UV, and MS[27]No activity reported to date
Metabolites 14 00081 i039
301.1314
40
geijedimerine
G. balansae (leaves)Chemical derivatisation, 1H NMR, IR, UV, and MS[28]No activity reported to date
Metabolites 14 00081 i040
454.1893
41
hordenine
G. balansae (leaves)1H NMR, IR, UV, and MS[27]Diuretic, disinfectant, antihypotensive agent. Used for treatment of dysentery. Antifeedant for grasshoppers [67].
Metabolites 14 00081 i041
165.1154
(Key: G.bG. balansae, G.pG. parviflora, G.sG. salicifolia).

3.3. Terpenes and Terpenoids

In total, sixty-four different terpenes/terpenoids have been isolated from the genus Geijera including monoterpenes, 42–55, monoterpenoids, 56–66, sesquiterpenes, 67–86, sesquiterpenoids 87–104, and the triterpene β-sitosterol 105. Although many of the terpenes that have been reported within the Geijera species are minor constituents of the leaf essential oils, they have been included in this review due to the possibility that they might contribute to the overall biological activity displayed by the plant extracts through combined and/or synergistic action together with the other active constituents. It is evident that the unequivocal identification of several of the compounds reported via GC-MS analysis requires further characterisation using spectroscopic techniques to aid in the confirmation of their structures. This is especially important for the disambiguation of the structures of geometric isomers and stereoisomers that have been reported.
Initial investigations of the essential oils of G. parviflora conducted by Penfold determined the presence of at least two chemotypes; the first one (1) was dominated by the terpenes pinene (49, 50) and camphene 51, which constituted 80% of the essential oils; while the other (2) contained an abundance of brevifolin 106 (a phenolic ketone) and the sesquiterpene azulene 67 [17,18,19]. Azulene 67 has been isolated as part of both the leaf essential oils of G. parviflora and G. salicifolia, respectively. Azulene is unique as it is one of the few naturally occurring pigments that is blue in colour, and it is responsible for the deep blue colour of the leaf oil from its G. parviflora chemotype [16,18]. Brophy and Goldsack continued this research and identified a total of four G. parviflora chemotypes, the two previously identified by Penfold, together with (3) a chemotype in which the terpenoid linalool 61 and the sesquiterpenoid β-eudesmol 96 were dominant, and another (4) in which the sesquiterpenes pregeijerene 68, geijerene 70, and the terpenoid linalool 61 were the major constituents [16]. The brevifolin-dominated chemotype (2) also contained spathulenol 102, globulol 92, and viridiflorol 98 as major constituents, with a very small proportion of monoterpenes. However, since the sample subjected to investigation was a few years old, it is unclear if any of the volatiles/monoterpenes had been lost from the extract, and it is possible that the large proportion of spathulenol 102, globulol 92, and viridiflorol 98 could be artefacts formed by oxidation of bicyclogermacrene 77 [16].
Two chemotypes of G. salicifolia exist; one containing pinene (49, 50), camphene 51, and limonene 45 as the dominant compounds; while the second chemotype contains large amounts of the phenolic ketone, brevifolin 106. Brevifolin 106 forms a large proportion of the essential oil of this chemotype and is obtained from the leaves via hydro-distillation [16]. G. linearifolia has not been found to exhibit different chemotypes, and its essential oils are dominated by spathulenol 102, geranyl acetate 57, bicyclogermacrene 77, and (E,E)-farnesol 87 [16]. There is scope for characterisation of the terpenes from G. balansae, which has been neglected because the studies performed on this species only targeted the isolation of alkaloids.
Terpenes and terpenoids are ubiquitous in the plant kingdom and they form the most diverse and abundant classes of secondary metabolites found in nature. They exhibit a large variety of pharmacological activities such as anti-microbial, anti-inflammatory, neuroactive, psychoactive, anti-cancer, anti-oxidant, and pest resistance, as well as several other activities [82]. This is also reflected in the range of activities displayed by the terpenes/terpenoids that have been identified within the Geijera species.
Monoterpenes: To date, fourteen monoterpenes 42–55 have been identified from the Geijera species, all of which have been identified in the leaf essential oils of the plants (Table 4).
Monoterpenoids: Six acyclic monoterpenoids 56–61, and five cyclic monoterpenoids 62–66, have been identified as part of the leaf essential oils (Table 4).
Sesquiterpenes: Seven cyclic sesquiterpene 68, 70, 75, 76, 80–82, ten bicyclic sesquiterpenes 67, 69, 72–74, 77–79, 83–84, two tricyclic sesquiterpene 71, and 85, as well as one open-chain sesquiterpene, 86, have been isolated as part of the leaf essential oils (Table 4).
Sesquiterpenoids: Two acyclic sesquiterpenoids 87, 99, one cyclic sesquiterpenoid 89, seven bicyclic sesquiterpenoids 88, 94–97, 101, 103 and eight tricyclic sesquiterpenoids 90–93, 98, 100, 102 and 104 have been isolated from the leaves of G. parviflora, G. salicifolia and G. linearifolia (Table 4).
Triterpene: One triterpene, β-sitosterol 105 was isolated from the leaves of G. salicifolia (Table 4).
Table 4. Terpenes and terpenoids identified within the genus Geijera.
Table 4. Terpenes and terpenoids identified within the genus Geijera.
Compound and Exact Mass (Da)SourceMethod of IdentificationReferencePharmacological Activity of Compound (Various Sources)
42
(E)-β-ocimene
G. linearifolia (leaves)
G. salicifolia (leaves)
G. parviflora (leaves)
GC-MS[16]Anticonvulsant, antifungal, antitumour, plant pest resistance and attraction of plant pollinators (semiochemical) [83]
Metabolites 14 00081 i042
136.1252
43
(Z)-β-ocimene
G. linearifolia (leaves)
G. salicifolia (leaves)
G. parviflora (leaves)
GC-MS[16]Anticonvulsant, antifungal, antitumour, plant pest resistance and attraction of plant pollinators (semiochemical) [83]
Metabolites 14 00081 i043
136.1252
44
myrcene
G. parviflora (leaves)
G. salicifolia (leaves)
GC-MS[16]Sedative, muscle relaxant, anti-inflammatory, analgesic, anti-tumour, antioxidant, psychotropic, antibiotic, antimutagenic [84,85]
Metabolites 14 00081 i044
136.1252
45
limonene
G. salicifolia (leaves)GC-MS[16]Anxiolytic, anti-carcinogenic [84]
Metabolites 14 00081 i045
136.1252
46
α-terpinene
G. parviflora (leaves)
G. salicifolia (leaves)
GC-MS[16]Antioxidant, antimicrobial, acetylcholinesterase inhibition, sedative [85,86]
Metabolites 14 00081 i046
136.1252
47
γ-terpinene
G. parviflora (leaves)
G. salicifolia (leaves)
GC-MS[16]Antioxidant, antimicrobial, acetylcholinesterase inhibition, antinociceptive, anti-inflammatory [86,87,88]
Metabolites 14 00081 i047
136.1252
48
terpinolene
G. parviflora (leaves)
G. salicifolia (leaves)
GC-MS[16]Antioxidant, antimicrobial, larvicide, insecticide [86,89]
Metabolites 14 00081 i048
136.1252
49
α-pinene
G. parviflora (leaves)
G. salicifolia (leaves)
Chemical derivatisation (G.p)

GC-MS (G.s)
[16,18]Anti-inflammatory, anti-tumour [84]
Metabolites 14 00081 i049
136.1252
50
β-pinene
G. parviflora (leaves)
G. salicifolia (leaves)
GC-MS[16]Anti-inflammatory, anti-tumour [84]
Metabolites 14 00081 i050
136.1252
51
camphene
G. parviflora (leaves)Chemical derivatisation[18]Antioxidant [90]
Metabolites 14 00081 i051
136.1252
52
sabinene
G. parviflora (leaves)
G. salicifolia (leaves)
GC-MS[16]Antioxidant, anti-inflammatory [91,92]
Metabolites 14 00081 i052
136.1252
53
α-phellandrene
G. parviflora (leaves)GC-MS[16]Antinociceptive, hyperthermic, promotes immune response, anti-cancer, antimicrobial, fungicide, pesticide [93]
Metabolites 14 00081 i053
136.1252
54
β-phellandrene
G. parviflora (leaves)
G. salicifolia (leaves)
GC-MS[16]Acetylcholinesterase inhibitor, antifungal, expectorant [94,95]
Metabolites 14 00081 i054
136.1252
55
p-cymene
G. salicifolia (leaves)
G. parviflora (leaves)
GC-MS[16]Antioxidant, anti-inflammatory, anti-cancer, antimicrobial [96]
Metabolites 14 00081 i055
134.1096
56
citronellyl acetate
G. linearifolia (leaves)GC-MS[16]Pro-apoptotic activity in HepG2, fungicide, larvicide, bactericide, insect repellent/insecticide, antinociceptive [97]
Metabolites 14 00081 i056
196.1620
57
geranyl acetate
G. linearifolia (leaves)GC-MS[16]Anti-cancer, antifungal [98,99]
Metabolites 14 00081 i057
196.1463
58
neryl acetate
G. linearifolia (leaves)GC-MS[16]Fragrance and flavouring agent, strengthens skin barrier function [67,100]
Metabolites 14 00081 i058
196.1463
59
nerol
G. linearifolia (leaves)GC-MS[16]Antimicrobial [101]
Metabolites 14 00081 i059
154.1358
60
geraniol
G. linearifolia (leaves)GC-MS[16]Antimicrobial [101]
Metabolites 14 00081 i060
154.1358
61
linalool
G. linearifolia (leaves)
G. salicifolia (leaves)
G. parviflora (leaves)
GC-MS[16]Anxiolytic, antibacterial, anti-inflammatory [102,103,104]
Metabolites 14 00081 i061
154.1358
62
α-terpineol
G. parviflora (leaves)
G. salicifolia (leaves)
GC-MS[16] Antioxidant, anti-cancer, anticonvulsant, antiulcer, antihypertensive, antinociceptive, enhances skin penetration, insecticidal properties [105]
Metabolites 14 00081 i062
154.1358
63
terpinen-4-ol
G. parviflora (leaves)
G. salicifolia (leaves)
GC-MS[16]Anti-inflammatory, antifungal, anti-cancer, antibacterial [106,107,108,109,110]
Metabolites 14 00081 i063
154.1358
64
1,8-cineole (eucalyptol)
G. parviflora (leaves)
G. salicifolia (leaves)
GC-MS[16]Anti-inflammatory, antioxidant, analgesic, antifungal [107,111,112]
Metabolites 14 00081 i064
154.1358
65
camphor
G. parviflora (leaves)
G. salicifolia (leaves)
GC-MS[22]Insecticidal, antimicrobial, antiviral, anticoccidial, antinociceptive, anti-cancer, antitussive, skin penetration enhancer [113]
Metabolites 14 00081 i065
152.1201
66
borneol
G. salicifolia (leaves)GC-MS[22]Enhances membrane permeability, antibacterial, antifungal, antispasmodic, choleretic, acesodyne, sedative [114,115]
Metabolites 14 00081 i066
154.1358
67
azulene
G. parviflora (leaves)Chemical derivatisation[18]Anti-inflammatory [116]
Metabolites 14 00081 i067
128.0626
68
pregeijerene
G. salicifolia (leaves)
G. parviflora (leaves)
Chemical derivatisation, degradative analysis, and UV[29]Antifeedant, oviposition deterrence [117]
Metabolites 14 00081 i068
162.1409
69
cogeijerene
G. salicifolia (leaves)Chemical derivatisation, degradative analysis, and UV (G.s)[29,118]No activity reported to date
Metabolites 14 00081 i069
162.1409G. parviflora (leaves)Chemical derivatisation, degradative analysis, IR, and UV (G.p)
70
geijerene
G. parviflora (leaves)Combustion analysis, chemical derivatisation, degradative analysis, IR (G.p)[16,18,119]Antifeedant, oviposition deterrence [117]
Metabolites 14 00081 i070
164.1565G. salicifolia (leaves)GC-MS (G.s)
71
viridiflorene (ledene)
G. linearifolia (leaves)GC-MS[16]Antifungal [120]
Metabolites 14 00081 i071
204.1878
72
α-selinene
G. parviflora (leaves)GC-MS[16]No activity reported to date
Metabolites 14 00081 i072
204.1878
73
β-selinene
G. parviflora (leaves)GC-MS[16]No activity reported to date
Metabolites 14 00081 i073
204.1878
74
selina-3, 7(11)-diene
G. parviflora (leaves)GC-MS[22]No activity reported to date
Metabolites 14 00081 i074
204.1878
75
germacrene B
G. salicifolia (leaves)GC-MS[22]Antimicrobial activity against Gram negative bacteria
[121]
Metabolites 14 00081 i075
204.1878
76
germacrene D
G. linearifolia (leaves)
G. salicifolia (leaves)
G. parviflora (leaves)
GC-MS[16,22]Anti proliferative, scavenging activity towards the ABTS radical, antibacterial, antifungal, insecticidal, repels herbivores, attracts pollinators [122,123]
Metabolites 14 00081 i076
208.2191
77
bicyclogermacrene
G. linearifolia (leaves)
G. salicifolia (leaves)
G. parviflora (leaves)
GC-MS[16]Larvicidal activity [124]
Metabolites 14 00081 i077
204.1878
78
α-bergamotene
G. parviflora (leaves)GC-MS[16]Antifeedant [125]
Metabolites 14 00081 i078
204.1878
79
δ-cadinene
G. parviflora (leaves)GC-MS[16]Acaricidal, antiproliferative and apoptotic [126,127]
Metabolites 14 00081 i079
204.1878
80
β-elemene
G. linearifolia (leaves)
G. salicifolia (leaves)
G. parviflora (leaves)
GC-MS[16]Anti-cancer, antineoplastic, reproductive toxicity [128,129]
Metabolites 14 00081 i080
204.1878
81
γ-elemene
G. parviflora (leaves)
G. salicifolia (leaves)
GC-MS[16]Larvicidal activity [130]
Metabolites 14 00081 i081
204.1878
82
α-caryophyllene (humulene)
G. salicifolia (leaves)GC-MS[22]Antibacterial, anti-inflammatory, antitumor, analgesic [131,132,133]
Metabolites 14 00081 i082
204.1878
83
β-caryophyllene
G. linearifolia (leaves)
G. salicifolia (leaves)
G. parviflora (leaves)
GC-MS[16]Anti-inflammatory, analgesic, antimalarial, antifungal, antibacterial, anti-tumour [84,134]
Metabolites 14 00081 i083
204.1878
84
α-santalene
G. parviflora (leaves)GC-MS[22]Insect repellent, semiochemical [125]
Metabolites 14 00081 i084
204.1878
85
aromadendrene
G. parviflora (leaves)
G. linearifolia (leaves)
G. salicifolia (leaves)
GC-MS[16,22]Antibacterial (MRSA and drug resistant pathogens) [135]
Metabolites 14 00081 i085
204.1878
86
(E,E)-α-farnesene
G. parviflora (leaves)
G. linearifolia (leaves)
G. salicifolia (leaves)
GC-MS[16]Semiochemical, antibacterial, anticariogenic, anti-cancer, anti-plasmodial, hepatoprotective, antioxidant, anti-inflammatory, antifungal [136,137]
Metabolites 14 00081 i086
204.1878
87
(E,E)-farnesol
G. linearifolia (leaves)GC-MS[16]Antibacterial, antifungal [138,139]
Metabolites 14 00081 i087
222.1984
88
guaiol
G. parviflora (leaves)
G. salicifolia (leaves)
GC-MS[22]Insecticide, antimicrobial, acaricidal, anti-cancer [140,141,142]
Metabolites 14 00081 i088
208.1827
89
elemol
G. parviflora (leaves)GC-MS[16]Antifungal [143]
Metabolites 14 00081 i089G. salicifolia (leaves)
222.1984
90
palustrol
G. linearifolia (leaves)GC-MS[16]Semiochemical [144]
Metabolites 14 00081 i090
222.1984
91
ledol
G. parviflora (leaves)GC-MS[22]Antifungal, toxic CNS effects, antitussive, expectorant [145,146]
Metabolites 14 00081 i091
222.1984
92
globulol
G. parviflora (leaves)GC-MS[16]Antimicrobial [147]
Metabolites 14 00081 i092
222.1984
93
epi-globulol
G. parviflora (leaves)GC-MS[16]Antimicrobial, semiochemical [148]
Metabolites 14 00081 i093
222.1984
94
τ-cadinol
G. linearifolia (leaves)GC-MS[16]Antitrypanosomal, smooth muscle relaxant, inhibits effects of cholera toxins [149,150]
Metabolites 14 00081 i094
207.1749
95
α-eudesmol
G. linearifolia (leaves)
G. parviflora (leaves)
G. salicifolia (leaves)
GC-MS[16]Antitrypanosomal, anti-cancer, anti-neurogenic inflammation [151,152,153]
Metabolites 14 00081 i095
222.1984
96
β-eudesmol
G. linearifolia (leaves)
G. parviflora (leaves)
G. salicifolia (leaves)
GC-MS[16]Anti-cancer, sedative, hepatoprotective, anti-inflammatory, diuretic, inhibits platelet aggregation, insect repellent, anti-allergy [67,152,154,155,156,157]
Metabolites 14 00081 i096
222.1984
97
γ-eudesmol
G. linearifolia (leaves)
G. parviflora (leaves)
G. salicifolia (leaves)
GC-MS[16]Anti-cancer [152]
Metabolites 14 00081 i097
222.1984
98
viridiflorol
G. parviflora (leaves)GC-MS[16]Anti-mycobacterial, anti-inflammatory, antioxidant [158]
Metabolites 14 00081 i098
222.1984
99
(E,E)-farnesal
G. linearifolia (leaves)GC-MS[16]Semiochemical [159]
Metabolites 14 00081 i099
220.1827
100
caryophyllene oxide
G. linearifolia (leaves)
G. salicifolia (leaves)
G. parviflora (leaves)
GC-MS[16]Anti-cancer, analgesic [134]
Metabolites 14 00081 i100
220.1827
101
caryophylla-4(12), 8(13)-dien-5-ol
G. parviflora (leaves)GC-MS[22]No activity reported to date
Metabolites 14 00081 i101
220.1827
102
spathulenol
G. linearifolia (leaves)
G. parviflora (leaves)
G. salicifolia (leaves)
GC-MS[16,22]Antioxidant, anti-inflammatory, antiproliferative, antimycobacterial, antimicrobial [160,161]
Metabolites 14 00081 i102
220.1827
103
eremophilone
G. parviflora (leaves)GC-MS[16,22]Cytotoxic, insecticidal, insect repellent, antifeedant (against termites) [162,163]
Metabolites 14 00081 i103
218.1671
104
cyclocolorenone
G. parviflora (leaves)GC-MS[16,22]Antifeedant, antimicrobial, allelopathic, anti-inflammatory, insect repellent [164]
Metabolites 14 00081 i104
218.1671
105
β-sitosterol
G. salicifolia (leaves)Melting point and IR[37]Anti-cancer, anthelminthic, antimutagenic [165,166]
Metabolites 14 00081 i105
414.3862
(Key: G.lG. linearifolia, G.pG. parviflora, G.sG. salicifolia).

3.4. Miscellaneous Compounds Isolated

Phenolic derivatives, brevifolin 106, and elemicin 107, have been identified within the leaf essential oils of G. parviflora. Brevifolin 106 also forms a large proportion of the essential oil from one chemotype of G. salicifolia, obtained from the leaves via hydro-distillation, and it is also present in the bark of G. balansae. A flavonoid 3,5,8,4′-tetrahydroxy-6,7-dimethoxyflavone 108; a benzyl alcohol ester 2-phenylethyl isobutyrate 109, fatty acid ester isoamyl isovalerate 110, cyclic ketone cis-jasmone 111, phenylpropanoid methyl eugenol 112; and a benzene dicarboxylic acid (phthalic acid) 113 were also isolated from the leaves of G. parviflora. Additionally, four phenolic compounds 114–117 (vanillin, methyl syringate, methyl and ethyl ferulates, respectively) were isolated from the wood of G. balansae (Table 5).
The miscellaneous compounds isolated from the Geijera species exhibit a variety of pharmacological activities, as summarised in Table 5.
Table 5. Miscellaneous compounds isolated from the genus Geijera.
Table 5. Miscellaneous compounds isolated from the genus Geijera.
Compound and Exact Mass (Da)SourceMethod of IdentificationReferencePharmacological Activity of Compound (Various Sources)
106
brevifolin (xanthoxylin)
G. parviflora (leaves)
G. balansae (bark)
G. salicifolia (leaves)
GC-MS (G.p)
1H NMR, IR, UV, and MS (G.b)
Melting point (G.s)
[16,18,28]Antioxidant, hepatoprotective, antibacterial, antifungal, antinociceptive, antiedematogenic and antispasmodic [167,168]
Metabolites 14 00081 i106
196.0736
107
elemicin
G. parviflora (leaves)GC-MS[9]Psychotropic, antimicrobial, antioxidant, acetylcholinesterase inhibitor, antiviral [9,169,170]
Metabolites 14 00081 i107
208.1099
108
3,5,8,4′-tetrahydroxy-6,7-dimethoxyflavone
G. parviflora (leaves)1H and 13C NMR[10]No activity reported to date
Metabolites 14 00081 i108
346.0689
109
2-phenylethyl isobutyrate
G. parviflora (leaves)1H and 13C NMR[10]Odorant [171]
Metabolites 14 00081 i109
192.1150
110
isoamyl isovalerate
G. parviflora (leaves)1H and 13C NMR[10]Flavouring/odorant [172]
Metabolites 14 00081 i110
172.1463
111
cis-jasmone
G. parviflora (leaves)GC-MS[22]Semiochemical [173]
Metabolites 14 00081 i111
164.1201
112
methyl eugenol
G. parviflora (leaves)GC-MS[22]Attracts pollinator insects (semiochemical) [174]
Metabolites 14 00081 i112
178.0994
113
phthalic acid
G. parviflora (leaves)GC-MS[22]Endocrine disruptor [175]
Metabolites 14 00081 i113
166.0266
114
vanillin
G. balansae (wood)1H NMR, IR, UV, and MS[28]Flavouring, pharmaceutical excipient, antioxidant, inhibits lipid peroxidation [67]
Metabolites 14 00081 i114
152.0473
115
methyl syringate
G. balansae (wood)1H NMR, IR, UV, and MS[28]Anti-diabetic, TRPA1 agonist [176,177]
Metabolites 14 00081 i115
212.0685
116
methyl ferulate
G. balansae (wood)1H NMR, IR, UV, and MS[28]Inhibits COX-2 expression, blocks p-p38 and p-JNK in primary bone marrow derived-macrophages [178,179]
Metabolites 14 00081 i116
208.0736
117
ethyl ferulate
G. balansae (wood)1H NMR, IR, UV, and MS[28]Antioxidative, antiapoptotic, antirheumatic, neuroprotective and anti-inflammatory [180,181]
Metabolites 14 00081 i117
222.0892
(Key: G.lG. linearifolia, G.pG. parviflora, G.sG. salicifolia).

4. Pharmacological Activities of Geijera Constituents

Compounds that have been identified within the genus Geijera exhibit a variety of pharmacological behaviors which can be categorised into the following main types of activity:
  • Antimicrobial activity;
  • Antifungal activity;
  • Reduction in inflammation;
  • Reduction in pain;
  • Reduction in anxiety;
  • Muscle relaxant activity;
  • Anti-cancer and anti-tumour activity;
  • Antioxidant activity;
  • Acetylcholinesterase inhibition;
  • MAO-B inhibition;
  • Anticonvulsant activity;
  • Psychotropic activity;
  • Increase in membrane permeability;
  • Plant pest resistance/insecticidal/semiochemical activity.
The chemical constituents identified in the four studied Geijera species are enumerated in Table 6, according to the main types of activity reported. The pharmacological activities of novel alkaloids isolated from G. balansae, namely O-acetyl geibalansine 39 and geijedimerine 40, as well as the flindersine derivatives 4′-hydroxy-3′,4′-dihydroflindersine 31 and cis-3′,4′-dihydroxy-3′,4′-dihydroflindersine 32 are unknown, but in light of the activities reported from the other species of the genus, it would be worthwhile to examine these for any useful pharmacological properties.
The activities reported in Table 6 were obtained based on all the available literature for that chemical constituent. The purpose of this was to illustrate the range of pharmacological activities of these compounds, which can possibly support the customary uses of the plant.

4.1. Geijera Secondary Metabolites That Can Be Linked to Its Ethnobotanical Uses

The key pharmacological activities associated with the traditional use of G. parviflora are related to general analgesia, relief from toothache and infection, and the induction of psychoactive effects. These outcomes could arise from the following pharmacological activities as reported from specific secondary metabolites:
  • anti-inflammatory activity
  • analgesic/antinociceptive activity
  • antimicrobial, antifungal, and antioxidant activity
  • acetylcholinesterase inhibition, monoamine oxidase inhibition, muscle relaxant activity, sedative activity, anticonvulsant activity, and psychotropic activity (from neuro- and psycho-active compounds).
Although many of the active compounds identified are minor constituents, their combined activity (probable or possible synergistic activity) merits further investigation, in conjunction with the effects of compounds such as α-terpineol 62, camphor 65, and borneol 66, which increase membrane permeability and hence may facilitate greater uptake of the active compounds. It has been hypothesised that the observed activities of preparations from medicinal plants can be attributed not only to the pharmacological effects of the main constituents, but also to a synergy of action between the most and the less abundant active components found within these mixtures [182]. The occurrence of a large variety of active major and minor constituents as observed within G. parviflora, makes it an ideal candidate for studies to explore the validity and implications of this hypothesis. In addition, many of the pharmacological activities herein are only reported for in vitro assays. This further supports the necessity for further investigations to ascertain the suitability of specific lead compounds for therapeutic use.

4.1.1. Anti-Inflammatory, Analgesic, and Antinociceptive Compounds

Of the forty-four anti-inflammatory and analgesic compounds identified within the genus Geijera, thirty-four have been found in G. parviflora (Table 7). Since inflammation triggers cellular responses associated with pain and hyperalgesia, a decrease in inflammation should mitigate pain [183].
Several of the compounds in Table 7 display anti-inflammatory activity through the inhibition of inflammatory mediators. For example, caryophyllene oxide 100 was shown to inhibit cyclooxygenase and/or lipoxygenase, whereas compounds such as 13, 26, 30, and 35, act through the inhibition of nitric oxide and prostaglandin E2 production [57,73,92,106]. Banbury et al. suggested that the anti-inflammatory activities of flindersine 30 and its derivative (N-acetoxymethyl) flindersine 35, which act through prostaglandin E2 inhibition, could contribute significantly to pharmacological effects that justify the traditional use of the leaves of G. parviflora for analgesia [10].
In total, nine compounds occurring in G. parviflora leaves: 44, 47, 53, 62, 64, 65, 83, 100 and 106 have reported analgesic and/or antinociceptive activities, and these properties directly support the customary uses of this plant.

4.1.2. Antimicrobial, Antifungal, and Antioxidant Compounds

A total of sixty-one antimicrobial, antifungal, and antioxidant compounds were identified within the Geijera species. These compounds (from various sources) have reported activities against a broad range of microbial and fungal pathogens, as well as significant antioxidant activities which may serve to support healthy immune responses and decrease the incidence of inflammatory conditions and resultant pain. Of these compounds, forty-one have been identified in G. parviflora (Table 8).
The furanocoumarin angelicin (isopsoralen) 16, found in G. parviflora leaves, has reported activities against gamma-herpes viruses and periodontal disease [61,184], and these activities are congruent with the traditional use of the plant for toothache. Antimicrobial constituents such as hexadecanoyl anthranilic acid 24, and the mixture of three anthranilic acid derivatives 20, 21, 22 from G. parviflora leaves displayed antibacterial activity against several Gram-positive strains, including a methicillin-resistant strain of Staphylococcus aureus [68]. Of particular interest, is that a quinolone isolated from the bark of G. balansae, 4-methoxy N-methyl-2-quinolone 37, displays significant activity against Methicillin resistant Staphylococcus aureus (MRSA) with an IC50 value of 8.0 µM [80].

4.1.3. Neuroactive and Psychoactive Compounds

The twenty-one compounds distributed within Geijera that display neuroactive and psychoactive effects are categorised in Table 9. In addition to these, the coumarin osthole 15 (from G. parviflora leaves) and the ferulic acid derivative ethyl ferulate 117 (from G. balansae wood) also possess neuroprotective properties [181,185]. A total of fifteen neuroactive and psychoactive compounds have been reported from G. parviflora.
In this group of compounds, geiparvarin 2 has been shown to be a strong and selective monoamine oxidase B inhibitor [43].
These constituents are present in minor quantities which may not be sufficient to produce psychoactive effects if taken orally (due to their metabolism in the digestive tract). However, the traditional use of G. parviflora for the purpose of inducing intoxication involves smoking the plant, and there may be high enough concentrations of actives (or pyrolysed actives) present within the smoke (which is absorbed directly into the bloodstream via the lungs) to induce intoxicating effects [22]. Preliminary investigation of smoke condensates from G. parviflora carried out by Sadgrove et al. did not yield definitive results [9]. Hence, there is scope for further work to be undertaken in order to refine the methodology devised to simulate the smoke preparations that are created during traditional use of G. parviflora, which are often produced in conjunction with other plant materials, so that any psychoactive constituents within these complex mixtures can be accurately determined and assayed for their combined activity, as well as their individual activities, in this context.

4.1.4. Anti-Cancer Compounds

The most noteworthy anti-tumour compound isolated from the genus Geijera is geiparvarin 2, which displays significant in vitro cytostatic activity and antiproliferative activity against various tumour cell lines [42,186]. The bioactivity of 2 was attributed to the furan-3 (2H) moiety, which was suggested by Borges et al. to act as an alkylating agent against bio-nucleophiles [41]. Geiparvarin 2 and 2′,3′-dihydrogeiparvarin 6 also display significant in vitro activity against human carcinoma of the nasopharynx [48,49]. Derivatives of geiparvarin 2 have been developed with increased cytotoxic activity, suggesting that this compound could provide a useful lead in the development of new anti-tumour agents [42].
In total, forty-one compounds displaying anti-cancer activities were reported within the genus Geijera, with thirty-three of these occurring in G. parviflora (Table 10). Although it is beyond the scope of this review to provide details of the various cancer cell lines that these compounds are active against, the number of compounds with anti-cancer activity present in G. parviflora especially, provides a good argument for the value and use of this plant in customary medicine.

4.1.5. Compounds That Offer Pest Resistance, Insecticidal and Semiochemical Benefits

There are twenty-six compounds identified within the genus Geijera which have been observed in other studies to display useful botanical activities, including the ability to confer resistance from plant pests, provide protection from deleterious insects, and provide other semiochemical benefits such as anti-feedant activity and attraction of pollinators. Of these, twenty-one such compounds occur in G. parviflora (Table 11).
It would be useful to test extracts or isolates obtained directly from the Geijera species for the same or additional activities, such as antiparasitic activity. Based on the activities displayed here, there is scope for the development of formulations based on the constituents of Geijera, which could provide beneficial alternatives to conventional insect repellents as well as insecticides and pesticides in agricultural settings.

4.2. Future Perspectives

The traditional use of G. parviflora as an analgesic is supported by the identification of over thirty compounds within the plant, which display relevant pharmacological activities in this area. A promising range of active compounds has been discovered within other species of the genus, giving impetus for further natural product characterisation. Exploratory studies into synergistic effects are also warranted.
Most of the compounds identified within the genus Geijera have been isolated from the leaves of the plants. However, on the basis of the variety of active constituents that have been found within this species and its genus, it would be prudent to study the parts of the plant which have not received as much scientific attention, namely the fruits/seeds, which have previously yielded the alkaloid flindersine 30 [44].
The two New Caledonian species G. cauliflora, and G. tartarea, which have not been studied to date, should also be prioritised for future study.
Improvements in NMR and mass spectroscopy, and the development of new technologies for analytical separations and chemical profiling (LC/MS) have occurred in the decades since these studies were first performed. These advances mean that further compounds, including new structure derivatives, could be discovered. This could provide useful information in terms of the structure–activity relationships (SAR) of the currently known active compounds. In addition, a chemical profiling study that is focused on lead-like compounds, which compares the chemical profiles of different parts of the plants such as the leaves, fruits, and bark/wood, would also be beneficial to perform as an aid in further compound discovery. Further studies exploring a greater range of biological/physiological activities, beyond the traditional applications, are also worthwhile. This would include examining the agrochemical potential and bioactivity in a range of assays beyond those listed in this review, as well as exploration of the synthesis of active metabolites and/or their large-scale production, such as implementation of callus cultures. No studies have been conducted on the effect of the growing conditions on the production of secondary metabolites, nor has there been enough study of the plants in this genus to be able to establish whether specific compounds/classes observed could be chemotaxonomic markers. It is important to note that the pharmacological activities of the novel alkaloids O-acetyl geibalansine 39 and geijedimerine 40, as well as the flindersine derivatives 4′-hydroxy-3′,4′-dihydroflindersine 31 and cis-3′,4′-dihydroxy-3′,4′-dihydroflindersine 32 isolated from G. balansae are unknown, but in the light of the activities reported from the other alkaloids of this genus, it would be helpful to examine these for useful pharmacological properties. This would include refining the methodology to extract these compounds, revisiting the complete characterisation of some of the compounds listed in this review, and exploring synthetic routes for their production.

5. Conclusions

Plants of the genus Geijera are a rich source of biologically active compounds which encompass terpenes, terpenoids, coumarins, quinolones, and anthranilic acid derivatives. The traditional use of G. parviflora in the Indigenous Australian context is supported by the presence of compounds with significant anti-inflammatory, analgesic, antioxidant, antimicrobial, and antifungal activity. The psychoactive, neuroactive, and neuroprotective aspects of constituents inferred from the traditional uses of G. parviflora, in conjunction with their reported activities, merit further detailed investigation. Studies undertaken in recent years have highlighted many of the biological activities of the chemical constituents within these plants including anti-cancer, antimicrobial, antifungal, and pest resistant properties. With such a wealth of bioactivity, compounds from the various species of Geijera still hold potential to provide new therapeutic agents. This justifies a thorough phytochemical investigation of the constituents of the two neglected species, G. cauliflora, and G. tartarea. Furthermore, based on the reported activities exhibited by their chemical constituents, additional research on the pharmacological potential of all the plant components, including the roots, stems, bark, leaves, and flowers, from the entire genus Geijera is justified.

Author Contributions

Investigation, D.D. and R.J.B.; writing—original draft preparation, D.D.; writing—review and editing, D.D., R.B., C.R. and S.U.; supervision, S.U. All authors have read and agreed to the published version of the manuscript.

Funding

This research is supported by an Australian Government Research Training Program (RTP) Scholarship.

Institutional Review Board Statement

Not Applicable.

Informed Consent Statement

Not Applicable.

Data Availability Statement

Not Applicable.

Acknowledgments

In the spirit of Reconciliation, the authors acknowledge the Traditional Custodians of country throughout Australia and their connections to land, sea, and community. The authors would like to acknowledge the Wurundjeri people of the Kulin Nations as the Traditional Owners of the land on which RMIT University stands. We pay our respect to their Elders past, present, and future and we extend that respect to all Aboriginal and Torres Strait Islander peoples.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. IPNI. International Plant Names Index. Available online: https://www.ipni.org/?f=&sort=published_desc&q=Geijera (accessed on 12 December 2023).
  2. POWO. Geijera Schott|Plants of the World Online|Kew Science. Available online: http://powo.science.kew.org/taxon/urn:lsid:ipni.org:names:35743-1 (accessed on 12 December 2023).
  3. ALA. Genus: Geijera. Available online: https://bie.ala.org.au/species/https://id.biodiversity.org.au/node/apni/2905474 (accessed on 12 December 2023).
  4. Hartley, T.G. Flora of Australia: Meliaceae, Rutaceae, Zygophyllaceae; ABRS/CSIRO Australia: Clayton, VIC, Australia, 2013; Volume 26.
  5. Bruy, D.; Lannuzel, G.; Gâteblé, G.; Munzinger, J. Three new species threatened by mining activity in New Caledonia. Phytotaxa 2023, 578, 228–240. [Google Scholar] [CrossRef]
  6. Kubitzki, K.; Kallunki, J.A.; Duretto, M.; Wilson, P.G. Rutaceae; Springer: Berlin/Heidelberg, Germany, 2011; Volume 10, pp. 276–356. [Google Scholar]
  7. Packer, J.; Turpin, G.; Ens, E.; Venkataya, B.; Hunter, J.; Mbabaram, C.; Yirralka, R. Building partnerships for linking biomedical science with traditional knowledge of customary medicines: A case study with two Australian Indigenous communities. J. Ethnobiol. Ethnomed. 2019, 15, 69. [Google Scholar] [CrossRef] [PubMed]
  8. Parker, K.L. The Euahlayi Tribe: A Study of Aboriginal Life in Australia; Project Gutenberg: Salt Lake City, UT, USA, 1905. [Google Scholar]
  9. Sadgrove, N.J.; Jones, G.L. Characterization and Bioactivity of Essential Oils from Geijera parviflora (Rutaceae): A Native Bush Medicine from Australia. Nat. Prod. Commun. 2013, 8, 747–751. [Google Scholar] [CrossRef]
  10. Banbury, L.K.; Shou, Q.; Renshaw, D.E.; Lambley, E.H.; Griesser, H.J.; Mon, H.; Wohlmuth, H. Compounds from Geijera parviflora with prostaglandin E2 inhibitory activity may explain its traditional use for pain relief. J. Ethnopharmacol. 2015, 163, 251–255. [Google Scholar] [CrossRef] [PubMed]
  11. Cribb, A.B.; Cribb, J.W. Wild Medicine in Australia; Collins: Sydney, NSW, Australia, 1981. [Google Scholar]
  12. Lassak, E.V.; McCarthy, T. Australian Medicinal Plants; New Holland: Sydney, NSW, Australia, 2001. [Google Scholar]
  13. Ecological Cultural Knowledge-Paakantyi (Barkindji) Knowledge Shared by the Paakantyi (Barkindji) People. Available online: https://www.lls.nsw.gov.au/__data/assets/pdf_file/0007/1419784/WLLS-Paakantyi-Booklet-PURPLE-22.pdf (accessed on 12 December 2023).
  14. Ecological Cultural Knowledge-Ngiyampaa Knowledge Shared by the Ngiyampaa People. Available online: https://www.lls.nsw.gov.au/__data/assets/pdf_file/0003/737625/Ngiyampaa_Booklet_WEB-updated.pdf (accessed on 12 December 2023).
  15. Williams, A.; Sides, T. Wiradjuri Plant Use in the Murrumbidgee Catchment. Available online: https://www.lls.nsw.gov.au/__data/assets/pdf_file/0009/1270845/Wiradjuri-Plant-Use-in-the-Murrumbidgee-Catchment.pdf (accessed on 14 December 2023).
  16. Brophy, J.J.; Goldsack, R.J. The Leaf Oils of Coatesia and Geijera (Rutaceae) from Australia. J. Essent. Oil Res. 2005, 17, 169–174. [Google Scholar] [CrossRef]
  17. Penfold, A.R. Natural Chemical Resources of Australian Plant Products. Part II. J. Chem. Educ. 1932, 9, 429–438. [Google Scholar] [CrossRef]
  18. Penfold, A.R.; Simonsen, J.L. The essential oils of three species of Geijera and the occurrence of a new hydrocarbon. Part I. J. Proc. R. Soc. N. S. W. 1930, 63–64, 264–297. [Google Scholar] [CrossRef]
  19. Penfold, A.R.; Simonsen, J.L. The essential oils of three species of Geijera and the occurrence of a new hydrocarbon, Part II. J. Proc. R. Soc. N. S. W. 1932, 65–66, 332. [Google Scholar] [CrossRef]
  20. Lahey, F.N.; MacLeod, J.K. The Coumarins of Geijera Parviflora Lindl. Aust. J. Chem. 1967, 20, 1943–1955. [Google Scholar] [CrossRef]
  21. Sadgrove, N.J.; Lyddiard, D.; Jones, G.L. Bioactive volatiles from Geijera parviflora Lindl. (Rutaceae): Evidence for coumarin chemotypes. In Proceedings of the XXIX International Horticultural Congress on Horticulture: Sustaining Lives, Livelihoods and Landscapes (IHC2014): V World 1125, Brisbane, Australia, 25 October 2016; pp. 145–150. [Google Scholar] [CrossRef]
  22. Sadgrove, N.J.; Goncalves-Martins, M.; Jones, G.L. Chemogeography and antimicrobial activity of essential oils from Geijera parviflora and Geijera salicifolia (Rutaceae): Two traditional Australian medicinal plants. Phytochemistry 2014, 104, 60–71. [Google Scholar] [CrossRef]
  23. Floyd, A.G. Research Note No. 30 N.S.W. Rainforest Trees Part IV Family Rutaceae; Forestry Commission of New South Wales: Sydney, NSW, Australia, 1979; p. 72. [Google Scholar]
  24. Bodkin, F. Dharawal Pharmacopeia Collection; Western Sydney University: Penrith, NSW, Australia, 2021. [Google Scholar]
  25. Appelhans, M.S.; Bayly, M.J.; Heslewood, M.M.; Groppo, M.; Verboom, G.A.; Forster, P.I.; Kallunki, J.A.; Duretto, M.F. A new subfamily classification of the Citrus family (Rutaceae) based on six nuclear and plastid markers. Taxon 2021, 70, 1035–1061. [Google Scholar] [CrossRef]
  26. Waterman, P.G. Alkaloids of the rutaceae: Their distribution and systematic significance. Biochem. Syst. Ecol. 1975, 3, 149–180. [Google Scholar] [CrossRef]
  27. Ahond, A.; Poupat, C.; Pusset, J. Geibalansine et O-acétylgeibalansine, nouveaux alcaloïdes isolés de Geijera balansae. Phytochemistry 1979, 18, 1415–1416. [Google Scholar] [CrossRef]
  28. Mitaku, S.; Skaltsounis, A.-L.; Tillequin, F.; Koch, M.; Pusset, J.; Chauviere, G. Plantes de Nouvelle-Calédonie, XCVI. Alcaloïdes de Geijera balansae. J. Nat. Prod. 1985, 48, 772–777. [Google Scholar] [CrossRef]
  29. Jones, R.V.J.; Sutherland, M.D. Terpenoid chemistry. XV. 1,5-Dimethylcyclodeca-1,5,7-triene, the precursor of geijerene in Geijera parviflora (Lindley). Aust. J. Chem. 1968, 21, 2255–2264. [Google Scholar] [CrossRef]
  30. Wu, L.; Wang, X.; Xu, W.; Farzaneh, F.; Xu, R. The structure and pharmacological functions of coumarins and their derivatives. Curr. Med. Chem. 2009, 16, 4236–4260. [Google Scholar] [CrossRef] [PubMed]
  31. Gray, A.I.; Waterman, P.G. Coumarins in the Rutaceae. Phytochemistry 1978, 17, 845–864. [Google Scholar] [CrossRef]
  32. Levin, D.A. The Chemical Defenses of Plants to Pathogens and Herbivores. Annu. Rev. Ecol. Syst. 1976, 7, 121–159. [Google Scholar] [CrossRef]
  33. Yamane, H.; Konno, K.; Sabelis, M.; Takabayashi, J.; Sassa, T.; Oikawa, H. Chemical Defence and Toxins of Plants; Elsevier: Amsterdam, The Netherlands, 2010; pp. 339–385. [Google Scholar]
  34. Kingsbury, J.M. The Evolutionary and Ecological Significance of Plant Toxins. In Handbook of Natural Toxins Plant and Fungal Toxins; Keeler, R.F., Tu, A.T., Eds.; Marcel Dekker: New York, NY, USA, 1983; Volume 1. [Google Scholar]
  35. Shimizu, B.-I. 2-Oxoglutarate-dependent dioxygenases in the biosynthesis of simple coumarins. Front. Plant Sci. 2014, 5, 549. [Google Scholar] [CrossRef]
  36. Valenti, P.; Rampa, A.; Recanatini, M.; Bisi, A.; Belluti, F.; Da Re, P.; Carrara, M.; Cima, L. Synthesis, cytotoxicity and SAR of simple geiparvarin analogues. Anticancer Drug Des. 1997, 12, 443–451. [Google Scholar]
  37. Ritchie, E.; Taylor, W.C.; Young, L.M. Some extractives from Geijera salicifolia Schott. Aust. J. Chem. 1968, 21, 1381. [Google Scholar] [CrossRef]
  38. Mazimba, O. Umbelliferone: Sources, chemistry and bioactivities review. Bull. Fac. Pharm. 2017, 55, 223–232. [Google Scholar] [CrossRef]
  39. Şöhretoğlu, D.; Renda, G. Chapter Eleven—Medicinal natural products in osteoporosis. In Annual Reports in Medicinal Chemistry; Sarker, S.D., Nahar, L., Eds.; Academic Press: Cambridge, MA, USA, 2020; Volume 55, pp. 327–372. [Google Scholar]
  40. Rauf, A.; Khan, R.; Khan, H.; Pervez, S.; Pirzada, A.S. In vivo antinociceptive and anti-inflammatory activities of umbelliferone isolated from Potentilla evestita. Nat. Prod. Res. 2014, 28, 1371–1374. [Google Scholar] [CrossRef] [PubMed]
  41. Borges, F.; Roleira, F.; Milhazes, N.; Santana, L.; Uriarte, E. Simple Coumarins and Analogues in Medicinal Chemistry: Occurrence, Synthesis and Biological Activity. Curr. Med. Chem. 2005, 12, 887–916. [Google Scholar] [CrossRef] [PubMed]
  42. Chimichi, S.; Boccalini, M.; Salvador, A.; Dall’Acqua, F.; Basso, G.; Viola, G. Synthesis and biological evaluation of new geiparvarin derivatives. ChemMedChem 2009, 4, 769–779. [Google Scholar] [CrossRef]
  43. Carotti, A.; Carrieri, A.; Chimichi, S.; Boccalini, M.; Cosimelli, B.; Gnerre, C.; Carotti, A.; Carrupt, P.A. Natural and synthetic geiparvarins are strong and selective MAO-B inhibitors. Synthesis and SAR studies. Bioorg. Med. Chem. Lett. 2002, 12, 3551–3555. [Google Scholar] [CrossRef]
  44. Dreyer, D.L.; Lee, A. Extractives of Geijera Parviflora. Phytochemistry 1972, 11, 763–767. [Google Scholar] [CrossRef]
  45. Adams, D.H.; Shou, Q.; Wohlmuth, H.; Cowin, A.J. Native Australian plant extracts differentially induce Collagen I and Collagen III in vitro and could be important targets for the development of new wound healing therapies. Fitoterapia 2016, 109, 45–51. [Google Scholar] [CrossRef]
  46. Tayarani-Najaran, Z.; Tayarani-Najaran, N.; Eghbali, S. A Review of Auraptene as an Anticancer Agent. Front. Pharmacol. 2021, 12, 698352. [Google Scholar] [CrossRef]
  47. Kuo, P.-C.; Liao, Y.-R.; Hung, H.-Y.; Chuang, C.-W.; Hwang, T.-L.; Huang, S.-C.; Shiao, Y.-J.; Kuo, D.-H.; Wu, T.-S. Anti-Inflammatory and Neuroprotective Constituents from the Peels of Citrus grandis. Molecules 2017, 22, 967. [Google Scholar] [CrossRef]
  48. Padmawinata, K. Isolation and identification of cancer delaying compounds from the leaves of Geijera salicifolia. Acta Pharm. 1973, 4, 1–9. [Google Scholar]
  49. Davis, R.A.; Vullo, D.; Maresca, A.; Supuran, C.T.; Poulsen, S.A. Natural product coumarins that inhibit human carbonic anhydrases. Bioorg. Med. Chem. 2013, 21, 1539–1543. [Google Scholar] [CrossRef] [PubMed]
  50. Shou, Q.; Banbury, L.K.; Renshaw, D.E.; Smith, J.E.; He, X.; Dowell, A.; Griesser, H.J.; Heinrich, M.; Wohlmuth, H. Parvifloranines A and B, two 11-carbon alkaloids from Geijera parviflora. J. Nat. Prod. 2013, 76, 1384–1387. [Google Scholar] [CrossRef] [PubMed]
  51. Lahey, F.N.; Wluka, D.J. Geijerin: A new coumarin from the bark of Geijera salicifolia Schott. Aust. J. Chem. 1955, 8, 125. [Google Scholar] [CrossRef]
  52. Kwon, Y.; Kim, H.P.; Kim, M.J.; Chun, W. Acetylcholinesterase inhibitors from Angelica polymorpha stem. Nat. Prod. Sci. 2017, 23, 97–102. [Google Scholar] [CrossRef]
  53. Ramírez-Pelayo, C.; Martínez-Quiñones, J.; Gil, J.; Durango, D. Coumarins from the peel of citrus grown in Colombia: Composition, elicitation and antifungal activity. Heliyon 2019, 5, e01937. [Google Scholar] [CrossRef] [PubMed]
  54. Hui, Y.; Wang, X.; Yu, Z.; Fan, X.; Cui, B.; Zhao, T.; Mao, L.; Feng, H.; Lin, L.; Yu, Q.; et al. Scoparone as a therapeutic drug in liver diseases: Pharmacology, pharmacokinetics and molecular mechanisms of action. Pharmacol. Res. 2020, 160, 105170. [Google Scholar] [CrossRef]
  55. Golfakhrabadi, F.; Abdollahi, M.; Ardakani, M.R.; Saeidnia, S.; Akbarzadeh, T.; Ahmadabadi, A.N.; Ebrahimi, A.; Yousefbeyk, F.; Hassanzadeh, A.; Khanavi, M. Anticoagulant activity of isolated coumarins (suberosin and suberenol) and toxicity evaluation of Ferulago carduchorum in rats. Pharm. Biol. 2014, 52, 1335–1340. [Google Scholar] [CrossRef]
  56. Chen, Y.C.; Tsai, W.J.; Wu, M.H.; Lin, L.C.; Kuo, Y.C. Suberosin inhibits proliferation of human peripheral blood mononuclear cells through the modulation of the transcription factors NF-AT and NF-kappaB. Br. J. Pharmacol. 2007, 150, 298–312. [Google Scholar] [CrossRef]
  57. Bae, D.S.; Kim, C.Y.; Lee, J.K. Anti-inflammatory effects of dehydrogeijerin in LPS-stimulated murine macrophages. Int. Immunopharmacol. 2012, 14, 734–739. [Google Scholar] [CrossRef]
  58. Sun, M.; Sun, M.; Zhang, J. Osthole: An overview of its sources, biological activities, and modification development. Med. Chem. Res. 2021, 30, 1767–1794. [Google Scholar] [CrossRef] [PubMed]
  59. Liu, S.; Wu, D.; Xu, J.; Guan, S.; Sun, D. Research of the anxiolytic effect of osthol. Chin. Med. Her. 2012, 9, 19–21. [Google Scholar] [CrossRef] [PubMed]
  60. Wang, Y.; Hong, C.; Zhou, C.; Xu, D.; Qu, H.-b. Screening Antitumor Compounds Psoralen and Isopsoralen from Psoralea corylifolia L. Seeds. Evid.-Based Complement. Altern. Med. 2011, 2011, 363052. [Google Scholar] [CrossRef]
  61. Mahendra, C.K.; Tan, L.T.H.; Lee, W.L.; Yap, W.H.; Pusparajah, P.; Low, L.E.; Tang, S.Y.; Chan, K.G.; Lee, L.H.; Goh, B.H. Angelicin—A Furocoumarin Compound with Vast Biological Potential. Front. Pharmacol. 2020, 11, 366. [Google Scholar] [CrossRef] [PubMed]
  62. Khan, A.; Kunesch, G.; Chuilon, S.; Ravisé, A. Structure and biological activity of xanthyletin: A new phytoalexin of CITRUS. Fruits 1985, 40, 807–811. [Google Scholar]
  63. Cazal Cde, M.; Domingues Vde, C.; Batalhão, J.R.; Bueno, O.C.; Filho, E.R.; da Silva, M.F.; Vieira, P.C.; Fernandes, J.B. Isolation of xanthyletin, an inhibitor of ants’ symbiotic fungus, by high-speed counter-current chromatography. J. Chromatogr. A 2009, 1216, 4307–4312. [Google Scholar] [CrossRef] [PubMed]
  64. Erst, A.S.; Chernonosov, A.A.; Petrova, N.V.; Kulikovskiy, M.S.; Maltseva, S.Y.; Wang, W.; Kostikova, V.A. Investigation of Chemical Constituents of Eranthis longistipitata (Ranunculaceae): Coumarins and Furochromones. Int. J. Mol. Sci. 2022, 23, 406. [Google Scholar] [CrossRef]
  65. Tuan Anh, H.L.; Kim, D.-C.; Ko, W.; Ha, T.M.; Nhiem, N.X.; Yen, P.H.; Tai, B.H.; Truong, L.H.; Long, V.N.; Gioi, T.; et al. Anti-inflammatory coumarins from Paramignya trimera. Pharm. Biol. 2017, 55, 1195–1201. [Google Scholar] [CrossRef]
  66. PubChem. Xanthoxyletin. Available online: https://www.ncbi.nlm.nih.gov/pubmed/ (accessed on 14 December 2023).
  67. DNP. Dictionary of Natural Products. Available online: http://dnp.chemnetbase.com/dictionary-search.do?method=view&id=425027&si= (accessed on 15 December 2023).
  68. Shou, Q.; Banbury, L.K.; Maccarone, A.T.; Renshaw, D.E.; Mon, H.; Griesser, S.; Griesser, H.J.; Blanksby, S.J.; Smith, J.E.; Wohlmuth, H. Antibacterial anthranilic acid derivatives from Geijera parviflora. Fitoterapia 2014, 93, 62–66. [Google Scholar] [CrossRef]
  69. Johns, S.R.; Lamberton, J.A. Alkaloids of Geijera salicifolia Schott. (family Rutaceae): The identification of platydesmine and platydesmine acetate. Aust. J. Chem. 1966, 19, 1991. [Google Scholar] [CrossRef]
  70. Michael, J.P. Quinoline, quinazoline and acridone alkaloids. Nat. Prod. Rep. 2008, 25, 166–187. [Google Scholar] [CrossRef] [PubMed]
  71. Heinrich, M.; Mah, J.; Amirkia, V. Alkaloids Used as Medicines: Structural Phytochemistry Meets Biodiversity—An Update and forward Look. Molecules 2021, 26, 1836. [Google Scholar] [CrossRef]
  72. Szewczyk, A.; Pęczek, F. Furoquinoline Alkaloids: Insights into Chemistry, Occurrence, and Biological Properties. Int. J. Mol. Sci. 2023, 24, 12811. [Google Scholar] [CrossRef] [PubMed]
  73. Ratheesh, M.; Sindhu, G.; Helen, A. Anti-inflammatory effect of quinoline alkaloid skimmianine isolated from Ruta graveolens L. Inflamm. Res. 2013, 62, 367–376. [Google Scholar] [CrossRef] [PubMed]
  74. Yang, Z.-D.; Zhang, D.-B.; Ren, J.; Yang, M.-J. Skimmianine, a furoquinoline alkaloid from Zanthoxylum nitidum as a potential acetylcholinesterase inhibitor. Med. Chem. Res. 2012, 21, 722–725. [Google Scholar] [CrossRef]
  75. Zuo, Y.; Pu, J.; Chen, G.; Shen, W.; Wang, B. Study on the activity and mechanism of skimmianine against human non-small cell lung cancer. Nat. Prod. Res. 2019, 33, 759–762. [Google Scholar] [CrossRef]
  76. Ferreira, M.E.; Rojas de Arias, A.; Yaluff, G.; de Bilbao, N.V.; Nakayama, H.; Torres, S.; Schinini, A.; Guy, I.; Heinzen, H.; Fournet, A. Antileishmanial activity of furoquinolines and coumarins from Helietta apiculata. Phytomedicine 2010, 17, 375–378. [Google Scholar] [CrossRef]
  77. De Souza, R.C.; Fernandes, J.B.; Vieira, P.C.; da Silva, M.F.d.G.; Godoy, M.F.; Pagnocca, F.C.; Bueno, O.C.; Hebling, M.J.A.; Pirani, J.R. A new imidazole alkaloid and other constituents from Pilocarpus grandiflorus and their antifungal activity. Z. Für Naturforschung B 2005, 60, 787–791. [Google Scholar] [CrossRef]
  78. Duraipandiyan, V.; Ignacimuthu, S. Antibacterial and antifungal activity of Flindersine isolated from the traditional medicinal plant, Toddalia asiatica (L.) Lam. J. Ethnopharmacol. 2009, 123, 494–498. [Google Scholar] [CrossRef]
  79. Coy Barrera, C.A.; Coy Barrera, E.D.; Granados Falla, D.S.; Delgado Murcia, G.; Cuca Suarez, L.E. Seco-limonoids and quinoline alkaloids from Raputia heptaphylla and their antileishmanial activity. Chem. Pharm. Bull. 2011, 59, 855–859. [Google Scholar] [CrossRef]
  80. Rodríguez-Guzmán, R.; Johansmann Fulks, L.C.; Radwan, M.M.; Burandt, C.L.; Ross, S.A. Chemical Constituents, Antimicrobial and Antimalarial Activities of Zanthoxylum monophyllum. Planta Med. 2011, 77, 1542–1544. [Google Scholar] [CrossRef] [PubMed]
  81. Martínez-Pérez, E.F.; Juárez, Z.N.; Hernández, L.R.; Bach, H. Natural Antispasmodics: Source, Stereochemical Configuration, and Biological Activity. Biomed. Res. Int. 2018, 2018, 3819714. [Google Scholar] [CrossRef] [PubMed]
  82. Yang, W.; Chen, X.; Li, Y.; Guo, S.; Wang, Z.; Yu, X. Advances in Pharmacological Activities of Terpenoids. Nat. Prod. Commun. 2020, 15, 1934578X20903555. [Google Scholar] [CrossRef]
  83. Russo, E.B.; Marcu, J. Chapter Three-Cannabis Pharmacology: The Usual Suspects and a Few Promising Leads. In Advances in Pharmacology; Kendall, D., Alexander, S.P.H., Eds.; Academic Press: Cambridge, MA, USA, 2017; Volume 80, pp. 67–134. [Google Scholar]
  84. Louis, B.W.S. Cannabis as Medicine; Taylor & Francis Group: Milton, UK, 2019. [Google Scholar]
  85. Hazekamp, A.; Fischedick, J.T.; Díez, M.L.; Lubbe, A.; Ruhaak, R.L. 3.24-Chemistry of Cannabis. In Comprehensive Natural Products II; Liu, H.-W., Mander, L., Eds.; Elsevier: Oxford, UK, 2010; pp. 1033–1084. [Google Scholar]
  86. Carson, C.F.; Riley, T.V. Antimicrobial activity of the major components of the essential oil of Melaleuca alternifolia. J. Appl. Bacteriol. 1995, 78, 264–269. [Google Scholar] [CrossRef]
  87. Passos, F.F.d.B.; Lopes, E.M.; de Araújo, J.M.; de Sousa, D.P.; Veras, L.M.C.; Leite, J.R.S.A.; Almeida, F.R.d.C. Involvement of Cholinergic and Opioid System in γ-Terpinene-Mediated Antinociception. Evid.-Based Complement. Altern. Med. 2015, 2015, 829414. [Google Scholar] [CrossRef]
  88. Ramalho, T.; Pacheco de Oliveira, M.; Lima, A.; Bezerra-Santos, C.; Piuvezam, M. Gamma-Terpinene Modulates Acute Inflammatory Response in Mice. Planta Med. 2015, 81, 1248–1254. [Google Scholar] [CrossRef]
  89. Menezes, I.O.; Scherf, J.R.; Martins, A.O.B.P.B.; Ramos, A.G.B.; Quintans, J.d.S.S.; Coutinho, H.D.M.; Ribeiro-Filho, J.; de Menezes, I.R.A. Biological properties of terpinolene evidenced by in silico, in vitro and in vivo studies: A systematic review. Phytomedicine 2021, 93, 153768. [Google Scholar] [CrossRef]
  90. Tiwari, M.; Kakkar, P. Plant derived antioxidants–Geraniol and camphene protect rat alveolar macrophages against t-BHP induced oxidative stress. Toxicol. Vitr. 2009, 23, 295–301. [Google Scholar] [CrossRef]
  91. Quiroga, P.R.; Asensio, C.M.; Nepote, V. Antioxidant effects of the monoterpenes carvacrol, thymol and sabinene hydrate on chemical and sensory stability of roasted sunflower seeds. J. Sci. Food Agric. 2015, 95, 471–479. [Google Scholar] [CrossRef]
  92. Valente, J.; Zuzarte, M.; Gonçalves, M.J.; Lopes, M.C.; Cavaleiro, C.; Salgueiro, L.; Cruz, M.T. Antifungal, antioxidant and anti-inflammatory activities of Oenanthe crocata L. essential oil. Food Chem. Toxicol. 2013, 62, 349–354. [Google Scholar] [CrossRef]
  93. Thangaleela, S.; Sivamaruthi, B.S.; Kesika, P.; Tiyajamorn, T.; Bharathi, M.; Chaiyasut, C. A Narrative Review on the Bioactivity and Health Benefits of Alpha-Phellandrene. Sci. Pharm. 2022, 90, 57. [Google Scholar] [CrossRef]
  94. Bonesi, M.; Menichini, F.; Tundis, R.; Loizzo, M.R.; Conforti, F.; Passalacqua, N.G.; Statti, G.A.; Menichini, F. Acetylcholinesterase and butyrylcholinesterase inhibitory activity of Pinus species essential oils and their constituents. J. Enzym. Inhib. Med. Chem. 2010, 25, 622–628. [Google Scholar] [CrossRef] [PubMed]
  95. Williams, C. Medicinal Plants in Australia Volume 2: Gums, Resins, Tannin and Essential Oils; Rosenberg Publishing: Kenthurst, NSW, Australia, 2011; p. 300. [Google Scholar]
  96. Marchese, A.; Arciola, C.R.; Barbieri, R.; Silva, A.S.; Nabavi, S.F.; Tsetegho Sokeng, A.J.; Izadi, M.; Jafari, N.J.; Suntar, I.; Daglia, M.; et al. Update on Monoterpenes as Antimicrobial Agents: A Particular Focus on p-Cymene. Materials 2017, 10, 947. [Google Scholar] [CrossRef] [PubMed]
  97. Rios, E.; Rocha, N.; Carvalho, A.; Vasconcelos, L.; Dias, M.; Sousa, D.; Sousa, F.; Fonteles, M. TRP and ASIC channels mediate the antinociceptive effect of citronellyl acetate. Chem.-Biol. Interact. 2013, 203, 573–579. [Google Scholar] [CrossRef]
  98. Qi, F.; Yan, Q.; Zheng, Z.; Liu, J.; Chen, Y.; Zhang, G.J.J.B. Geraniol and geranyl acetate induce potent anticancer effects in colon cancer Colo-205 cells by inducing apoptosis, DNA damage and cell cycle arrest. J. BUON 2018, 23, 346–352. [Google Scholar]
  99. Khayyat, S.A.; Sameeh, M.Y. Bioactive epoxides and hydroperoxides derived from naturally monoterpene geranyl acetate. Saudi Pharm. J. 2018, 26, 14–19. [Google Scholar] [CrossRef] [PubMed]
  100. Lemaire, G.; Olivero, M.; Rouquet, V.; Moga, A.; Pagnon, A.; Cenizo, V.; Portes, P. Neryl acetate, the major component of Corsican Helichrysum italicum essential oil, mediates its biological activities on skin barrier. PLoS ONE 2023, 18, e0268384. [Google Scholar] [CrossRef]
  101. Jirovetz, L.; Buchbauer, G.; Schmidt, E.; Stoyanova, A.S.; Denkova, Z.; Nikolova, R.; Geissler, M. Purity, Antimicrobial Activities and Olfactoric Evaluations of Geraniol/Nerol and Various of Their Derivatives. J. Essent. Oil Res. 2007, 19, 288–291. [Google Scholar] [CrossRef]
  102. Harada, H.; Kashiwadani, H.; Kanmura, Y.; Kuwaki, T. Linalool Odor-Induced Anxiolytic Effects in Mice. Front. Behav. Neurosci. 2018, 12, 241. [Google Scholar] [CrossRef]
  103. Liu, X.; Cai, J.; Chen, H.; Zhong, Q.; Hou, Y.; Chen, W.; Chen, W. Antibacterial activity and mechanism of linalool against Pseudomonas aeruginosa. Microb. Pathog. 2020, 141, 103980. [Google Scholar] [CrossRef]
  104. Kim, M.-G.; Kim, S.-M.; Min, J.-H.; Kwon, O.-K.; Park, M.-H.; Park, J.-W.; Ahn, H.I.; Hwang, J.-Y.; Oh, S.-R.; Lee, J.-W.; et al. Anti-inflammatory effects of linalool on ovalbumin-induced pulmonary inflammation. Int. Immunopharmacol. 2019, 74, 105706. [Google Scholar] [CrossRef]
  105. Khaleel, C.; Tabanca, N.; Buchbauer, G. α-Terpineol, a natural monoterpene: A review of its biological properties. Open Chem. 2018, 16, 349–361. [Google Scholar] [CrossRef]
  106. Hart, P.H.; Brand, C.; Carson, C.F.; Riley, T.V.; Prager, R.H.; Finlay-Jones, J.J. Terpinen-4-ol, the main component of the essential oil of Melaleuca alternifolia (tea tree oil), suppresses inflammatory mediator production by activated human monocytes. Inflamm. Res. 2000, 49, 619–626. [Google Scholar] [CrossRef]
  107. Morcia, C.; Malnati, M.; Terzi, V. In vitro antifungal activity of terpinen-4-ol, eugenol, carvone, 1,8-cineole (eucalyptol) and thymol against mycotoxigenic plant pathogens. Food Addit. Contam. Part A Chem. Anal. Control Expo. Risk Assess. 2012, 29, 415–422. [Google Scholar] [CrossRef]
  108. Wu, C.-S.; Chen, Y.-J.; Chen, J.J.W.; Shieh, J.-J.; Huang, C.-H.; Lin, P.-S.; Chang, G.-C.; Chang, J.-T.; Lin, C.-C. Terpinen-4-ol Induces Apoptosis in Human Nonsmall Cell Lung Cancer in Vitro and in Vivo. Evid.-Based Complement. Altern. Med. 2012, 2012, 818261. [Google Scholar] [CrossRef] [PubMed]
  109. Calcabrini, A.; Stringaro, A.; Toccacieli, L.; Meschini, S.; Marra, M.; Colone, M.; Arancia, G.; Molinari, A.; Salvatore, G.; Mondello, F. Terpinen-4-ol, The Main Component of Melaleuca alternifolia (Tea Tree) Oil Inhibits the In Vitro Growth of Human Melanoma Cells. J. Investig. Dermatol. 2004, 122, 349–360. [Google Scholar] [CrossRef] [PubMed]
  110. Zhang, Y.; Feng, R.; Li, L.; Zhou, X.; Li, Z.; Jia, R.; Song, X.; Zou, Y.; Yin, L.; He, C.; et al. The Antibacterial Mechanism of Terpinen-4-ol Against Streptococcus agalactiae. Curr. Microbiol. 2018, 75, 1214–1220. [Google Scholar] [CrossRef]
  111. Juergens, U.R.; Dethlefsen, U.; Steinkamp, G.; Gillissen, A.; Repges, R.; Vetter, H. Anti-inflammatory activity of 1.8-cineol (eucalyptol) in bronchial asthma: A double-blind placebo-controlled trial. Respir. Med. 2003, 97, 250–256. [Google Scholar] [CrossRef]
  112. Yin, C.; Liu, B.; Wang, P.; Li, X.; Li, Y.; Zheng, X.; Tai, Y.; Wang, C.; Liu, B. Eucalyptol alleviates inflammation and pain responses in a mouse model of gout arthritis. Br. J. Pharmacol. 2020, 177, 2042–2057. [Google Scholar] [CrossRef] [PubMed]
  113. Chen, W.; Vermaak, I.; Viljoen, A. Camphor—A fumigant during the Black Death and a coveted fragrant wood in ancient Egypt and Babylon—A review. Molecules 2013, 18, 5434–5454. [Google Scholar] [CrossRef]
  114. Zhang, L.; Han, L.; Qin, J.; Lu, W.; Wang, J. The Use of Borneol as an Enhancer for Targeting Aprotinin-Conjugated PEG-PLGA Nanoparticles to the Brain. Pharm. Res. 2013, 30, 2560–2572. [Google Scholar] [CrossRef]
  115. Tabanca, N.; Kırımer, N.; Demirci, B.; Demirci, F.; Başer, K.H.C. Composition and Antimicrobial Activity of the Essential Oils of Micromeria cristata subsp. phrygia and the Enantiomeric Distribution of Borneol. J. Agric. Food Chem. 2001, 49, 4300–4303. [Google Scholar] [CrossRef] [PubMed]
  116. Ayaz, F.; Yuzer, A.; Ince, T.; Ince, M. Anti-Cancer and Anti-Inflammatory Activities of Bromo- and Cyano-Substituted Azulene Derivatives. Inflammation 2020, 43, 1009–1018. [Google Scholar] [CrossRef] [PubMed]
  117. Kiran, S.R.; Reddy, A.S.; Devi, P.S.; Reddy, K.J. Insecticidal, antifeedant and oviposition deterrent effects of the essential oil and individual compounds from leaves of Chloroxylon swietenia DC. Pest Manag. Sci. 2006, 55, 1116–1121. [Google Scholar] [CrossRef] [PubMed]
  118. Gough, J.; Powell, V.; Sutherland, M.D. Constitution and biogenesis of two new sesquiterpenes. Tetrahedron Lett. 1961, 2, 763–767. [Google Scholar] [CrossRef]
  119. Sutherland, M.D. Terpenoid chemistry. VII. The structure of geijerene. Aust. J. Chem. 1964, 17, 75–91. [Google Scholar] [CrossRef]
  120. Mokhtari, M.; Jackson, M.D.; Brown, A.S.; Ackerley, D.F.; Ritson, N.J.; Keyzers, R.A.; Munkacsi, A.B. Bioactivity-Guided Metabolite Profiling of Feijoa (Acca sellowiana) Cultivars Identifies 4-Cyclopentene-1,3-dione as a Potent Antifungal Inhibitor of Chitin Synthesis. J. Agric. Food Chem. 2018, 66, 5531–5539. [Google Scholar] [CrossRef] [PubMed]
  121. Rashid, S.; Rather, M.A.; Shah, W.A.; Bhat, B.A. Chemical composition, antimicrobial, cytotoxic and antioxidant activities of the essential oil of Artemisia indica Willd. Food Chem. 2013, 138, 693–700. [Google Scholar] [CrossRef]
  122. Casiglia, S.; Bruno, M.; Bramucci, M.; Quassinti, L.; Lupidi, G.; Fiorini, D.; Maggi, F. Kundmannia sicula (L.) DC: A rich source of germacrene D. J. Essent. Oil Res. 2017, 29, 437–442. [Google Scholar] [CrossRef]
  123. Myron, K.; Clarkson, B.; Gemmill, C. New Zealand Journal of Botany Biological flora of New Zealand 16: Pittosporum kirkii Hook.f. ex Kirk, Kirk’s kōhūhū, thick-leaved kohukohu. N. Z. J. Bot. 2020, 59, 112–136. [Google Scholar] [CrossRef]
  124. Govindarajan, M.; Benelli, G. Eco-friendly larvicides from Indian plants: Effectiveness of lavandulyl acetate and bicyclogermacrene on malaria, dengue and Japanese encephalitis mosquito vectors. Ecotoxicol. Environ. Saf. 2016, 133, 395–402. [Google Scholar] [CrossRef] [PubMed]
  125. Wang, F.; Park, Y.-L.; Gutensohn, M. Glandular trichome-derived sesquiterpenes of wild tomato accessions (Solanum habrochaites) affect aphid performance and feeding behavior. Phytochemistry 2020, 180, 112532. [Google Scholar] [CrossRef]
  126. Hui, L.-M.; Zhao, G.-D.; Zhao, J.-J. δ-Cadinene inhibits the growth of ovarian cancer cells via caspase-dependent apoptosis and cell cycle arrest. Int. J. Clin. Exp. Pathol. 2015, 8, 6046. [Google Scholar] [PubMed]
  127. Guo, X.; Shang, X.; Li, B.; Zhou, X.Z.; Wen, H.; Zhang, J. Acaricidal activities of the essential oil from Rhododendron nivale Hook. f. and its main compund, δ-cadinene against Psoroptes cuniculi. Vet. Parasitol. 2017, 236, 51–54. [Google Scholar] [CrossRef] [PubMed]
  128. Jiang, Z.; Jacob, J.A.; Loganathachetti, D.S.; Nainangu, P.; Chen, B. β-Elemene: Mechanistic Studies on Cancer Cell Interaction and Its Chemosensitization Effect. Front. Pharmacol. 2017, 8, 105. [Google Scholar] [CrossRef] [PubMed]
  129. Chen, W.; Weng, S.; Lv, M.; Chen, W.; Bi, Z.; Chen, H.; Luo, T.; Hu, H.; Liao, W. β-Elemene Inhibits Human Sperm Function by Affecting Sperm Vitality and Intracellular Calcium. Cell. Physiol. Biochem. 2018, 51, 2019–2029. [Google Scholar] [CrossRef] [PubMed]
  130. Benelli, G.; Govindarajan, M.; AlSalhi, M.S.; Devanesan, S.; Maggi, F. High toxicity of camphene and γ-elemene from Wedelia prostrata essential oil against larvae of Spodoptera litura (Lepidoptera: Noctuidae). Environ. Sci. Pollut. Res. Int. 2018, 25, 10383–10391. [Google Scholar] [CrossRef]
  131. Pichette, A.; Larouche, P.L.; Lebrun, M.; Legault, J. Composition and antibacterial activity of Abies balsamea essential oil. Phytother. Res. 2006, 20, 371–373. [Google Scholar] [CrossRef]
  132. Fernandes, E.S.; Passos, G.F.; Medeiros, R.; da Cunha, F.M.; Ferreira, J.; Campos, M.M.; Pianowski, L.F.; Calixto, J.B. Anti-inflammatory effects of compounds alpha-humulene and (−)-trans-caryophyllene isolated from the essential oil of Cordia verbenacea. Eur. J. Pharmacol. 2007, 569, 228–236. [Google Scholar] [CrossRef]
  133. Hartsel, J.A.; Eades, J.; Hickory, B.; Makriyannis, A. Chapter 53—Cannabis sativa and Hemp. In Nutraceuticals; Gupta, R.C., Ed.; Academic Press: Boston, MA, USA, 2016; pp. 735–754. [Google Scholar]
  134. Fidyt, K.; Fiedorowicz, A.; Strządała, L.; Szumny, A. β-caryophyllene and β-caryophyllene oxide—Natural compounds of anticancer and analgesic properties. Cancer Med. 2016, 5, 3007–3017. [Google Scholar] [CrossRef]
  135. Mulyaningsih, S.; Sporer, F.; Reichling, J.; Wink, M. Antibacterial activity of essential oils from Eucalyptus and of selected components against multidrug-resistant bacterial pathogens. Pharm. Biol. 2011, 49, 893–899. [Google Scholar] [CrossRef]
  136. Ishnava, K.B.; Chauhan, J.B.; Barad, M.B. Anticariogenic and phytochemical evaluation of Eucalyptus globules Labill. Saudi J. Biol. Sci. 2013, 20, 69–74. [Google Scholar] [CrossRef] [PubMed]
  137. Thakre, A.D.; Mulange, S.V.; Kodgire, S.S.; Zore, G.B.; Karuppayil, S.M. Effects of Cinnamaldehyde, Ocimene, Camphene, Curcumin and Farnesene on Candida albicans. Adv. Microbiol. 2016, 06, 627–643. [Google Scholar] [CrossRef]
  138. Cugini, C.; Calfee, M.W.; Farrow, J.M.; Morales, D.K.; Pesci, E.C.; Hogan, D.A. Farnesol, a common sesquiterpene, inhibits PQS production in Pseudomonas aeruginosa. Mol. Microbiol. 2007, 65, 896–906. [Google Scholar] [CrossRef]
  139. Shirtliff, M.E.; Krom, B.P.; Meijering, R.A.M.; Peters, B.M.; Zhu, J.; Scheper, M.A.; Harris, M.L.; Jabra-Rizk, M.A. Farnesol-Induced Apoptosis in Candida albicans. Antimicrob. Agents Chemother. 2009, 53, 2392–2401. [Google Scholar] [CrossRef] [PubMed]
  140. Liu, T.; Wang, C.-J.; Xie, H.-Q.; Mu, Q. Guaiol—A Naturally Occurring Insecticidal Sesquiterpene. Nat. Prod. Commun. 2013, 8, 1934578X1300801001. [Google Scholar] [CrossRef]
  141. Sadgrove, N.J.; Senbill, H.; Van Wyk, B.-E.; Greatrex, B.W. New Labdanes with Antimicrobial and Acaricidal Activity: Terpenes of Callitris and Widdringtonia (Cupressaceae). Antibiotics 2020, 9, 173. [Google Scholar] [CrossRef] [PubMed]
  142. Yang, X.; Zhu, J.; Wu, J.; Huang, N.; Cui, Z.; Luo, Y.; Sun, F.; Pan, Q.; Li, Y.; Yang, Q. (−)-Guaiol regulates autophagic cell death depending on mTOR signaling in NSCLC. Cancer Biol. Ther. 2018, 19, 706–714. [Google Scholar] [CrossRef]
  143. Monteiro, A.F.M.; de Moura, É.P.; de Sousa, N.F.; Muratov, E.; Bezerra, A.H.R.; Scotti, M.T.; Scotti, L. Prediction of antifungal activity, cytotoxicity risks and molecular docking against Malassezia furfur of constituents of citronella essential oil (Cymbopogon winterianus). In Proceedings of the MOL2NET, International Conference Series on Multidisciplinary Sciences, UNC, Chape Hill, NC, USA, 20 March–20 December 2019. [Google Scholar]
  144. Jaenson, T.G.; Pålsson, K.; Borg-Karlson, A.K. Evaluation of extracts and oils of tick-repellent plants from Sweden. Med. Vet. Entomol. 2005, 19, 345–352. [Google Scholar] [CrossRef]
  145. Jesionek, A.; Poblocka-Olech, L.; Zabiegala, B.; Bucinski, A.; Krauze-Baranowska, M.; Luczkiewicz, M. Validated HPTLC method for determination of ledol and alloaromadendrene in the essential oil fractions of Rhododendron tomentosum plants and in vitro cultures and bioautography for their activity screening. J. Chromatogr. B 2018, 1086, 63–72. [Google Scholar] [CrossRef]
  146. Dampc, A.; Luczkiewicz, M. Rhododendron tomentosum (Ledum palustre). A review of traditional use based on current research. Fitoterapia 2013, 85, 130–143. [Google Scholar] [CrossRef]
  147. Tan, M.; Zhou, L.; Huang, Y.; Wang, Y.; Hao, X.; Wang, J. Antimicrobial activity of globulol isolated from the fruits of Eucalyptus globulus Labill. Nat. Prod. Res. 2008, 22, 569–575. [Google Scholar] [CrossRef] [PubMed]
  148. Zuccolotto, T.; Bressan, J.; Lourenço, A.V.F.; Bruginski, E.; Veiga, A.; Marinho, J.V.N.; Raeski, P.A.; Heiden, G.; Salvador, M.J.; Murakami, F.S.; et al. Chemical, Antioxidant, and Antimicrobial Evaluation of Essential Oils and an Anatomical Study of the Aerial Parts from Baccharis Species (Asteraceae). Chem. Biodivers. 2019, 16, e1800547. [Google Scholar] [CrossRef] [PubMed]
  149. dos Santos, A.L.; Amaral, M.; Hasegawa, F.R.; Lago, J.H.G.; Tempone, A.G.; Sartorelli, P. (−)-T-Cadinol—A Sesquiterpene Isolated From Casearia sylvestris (Salicaceae)—Displayed In Vitro Activity and Causes Hyperpolarization of the Membrane Potential of Trypanosoma cruzi. Front. Pharmacol. 2021, 12, 734127. [Google Scholar] [CrossRef]
  150. Claeson, P.; Andersson, R.; Samuelsson, G. T-cadinol: A pharmacologically active constituent of scented myrrh: Introductory pharmacological characterization and high field 1H- and 13C-NMR data. Planta Med. 1991, 57, 352–356. [Google Scholar] [CrossRef] [PubMed]
  151. Otoguro, K.; Iwatsuki, M.; Ishiyama, A.; Namatame, M.; Nishihara-Tukashima, A.; Kiyohara, H.; Hashimoto, T.; Asakawa, Y.; Ōmura, S.; Yamada, H. In vitro antitrypanosomal activity of plant terpenes against Trypanosoma brucei. Phytochemistry 2011, 72, 2024–2030. [Google Scholar] [CrossRef] [PubMed]
  152. Bomfim, D.S.; Ferraz, R.P.C.; Carvalho, N.C.; Soares, M.B.P.; Pinheiro, M.L.B.; Costa, E.V.; Bezerra, D.P. Eudesmol Isomers Induce Caspase-Mediated Apoptosis in Human Hepatocellular Carcinoma HepG2 Cells. Basic Clin. Pharmacol. Toxicol. 2013, 113, 300–306. [Google Scholar] [CrossRef]
  153. Asakura, K.; Kanemasa, T.; Minagawa, K.; Kagawa, K.; Yagami, T.; Nakajima, M.; Ninomiya, M. α-Eudesmol, a P/Q-type Ca2+ channel blocker, inhibits neurogenic vasodilation and extravasation following electrical stimulation of trigeminal ganglion. Brain Res. 2000, 873, 94–101. [Google Scholar] [CrossRef]
  154. Ohara, K.; Misaizu, A.; Kaneko, Y.; Fukuda, T.; Miyake, M.; Miura, Y.; Okamura, H.; Yajima, J.; Tsuda, A. β-Eudesmol, an Oxygenized Sesquiterpene, Reduces the Increase in Saliva 3-Methoxy-4-Hydroxyphenylglycol after the “Trier Social Stress Test” in Healthy Humans: A Randomized, Double-Blind, Placebo-Controlled Cross-Over Study. Nutrients 2018, 11, 9. [Google Scholar] [CrossRef]
  155. Tyagi, V.; Singh, V.K.; Sharma, P.K.; Singh, V. Essential oil-based nanostructures for inflammation and rheumatoid arthritis. J. Drug Deliv. Sci. Technol. 2020, 60, 101983. [Google Scholar] [CrossRef]
  156. Han, N.R.; Moon, P.D.; Ryu, K.J.; Jang, J.B.; Kim, H.M.; Jeong, H.J. β-eudesmol suppresses allergic reactions via inhibiting mast cell degranulation. Clin. Exp. Pharmacol. Physiol. 2017, 44, 257–265. [Google Scholar] [CrossRef]
  157. Ali, A.; Tabanca, N.; Demirci, B.; Blythe, E.K.; Ali, Z.; Baser, K.H.C.; Khan, I.A. Chemical Composition and Biological Activity of Four Salvia Essential Oils and Individual Compounds against Two Species of Mosquitoes. J. Agric. Food Chem. 2015, 63, 447–456. [Google Scholar] [CrossRef]
  158. Trevizan, L.N.F.; Nascimento, K.F.d.; Santos, J.A.; Kassuya, C.A.L.; Cardoso, C.A.L.; Vieira, M.d.C.; Moreira, F.M.F.; Croda, J.; Formagio, A.S.N. Anti-inflammatory, antioxidant and anti-Mycobacterium tuberculosis activity of viridiflorol: The major constituent of Allophylus edulis (A. St.-Hil., A. Juss. & Cambess.) Radlk. J. Ethnopharmacol. 2016, 192, 510–515. [Google Scholar] [CrossRef] [PubMed]
  159. Francke, W.; Schulz, S. Pheromones; Elsevier: Amsterdam, The Netherlands, 1999; pp. 197–261. [Google Scholar]
  160. do Nascimento, K.F.; Moreira, F.M.F.; Alencar Santos, J.; Kassuya, C.A.L.; Croda, J.H.R.; Cardoso, C.A.L.; Vieira, M.d.C.; Góis Ruiz, A.L.T.; Ann Foglio, M.; de Carvalho, J.E.; et al. Antioxidant, anti-inflammatory, antiproliferative and antimycobacterial activities of the essential oil of Psidium guineense Sw. and spathulenol. J. Ethnopharmacol. 2018, 210, 351–358. [Google Scholar] [CrossRef] [PubMed]
  161. Fernandes, F.H.; Guterres, Z.d.R.; Violante, I.M.P.; Lopes, T.F.S.; Garcez, W.S.; Garcez, F.R. Evaluation of mutagenic and antimicrobial properties of brown propolis essential oil from the Brazilian Cerrado biome. Toxicol. Rep. 2015, 2, 1482–1488. [Google Scholar] [CrossRef] [PubMed]
  162. Beattie, K. Phytochemical Studies and Bioactivity of Centipeda and Eremophila Species; Southern Cross University: Lismore, NSW, Australia, 2009. [Google Scholar]
  163. Beattie, K.D.; Waterman, P.G.; Forster, P.I.; Thompson, D.R.; Leach, D.N. Chemical composition and cytotoxicity of oils and eremophilanes derived from various parts of Eremophila mitchellii Benth. (Myoporaceae). Phytochemistry 2011, 72, 400–408. [Google Scholar] [CrossRef] [PubMed]
  164. Ishii, T.; Shinjo, Y.; Miyagi, M.; Matsuura, H.; Abe, T.; Kikuchi, N.; Suzuki, M. Investigation of insect repellent activity of cyclocolorenone obtained from the red alga Laurencia intricata. Rec. Nat. Prod. 2019, 13, 81–84. [Google Scholar] [CrossRef]
  165. Raicht, R.F.; Cohen, B.I.; Fazzini, E.P.; Sarwal, A.N.; Takahashi, M. Protective effect of plant sterols against chemically induced colon tumors in rats. Cancer Res. 1980, 40, 403. [Google Scholar]
  166. Villaseñor, I.M.; Angelada, J.; Canlas, A.P.; Echegoyen, D. Bioactivity studies on β-sitosterol and its glucoside. Phytother. Res. 2002, 16, 417–421. [Google Scholar] [CrossRef]
  167. Ito, M.; Shimura, H.; Watanabe, N.; Tamai, M.; Hanada, K.; Takahashi, A.; Tanaka, Y.; Arai, I.; Zhang, P.-L.; Rao, C.; et al. Hepatorotective Compounds from Canarium album and Euphorbia nematocypha. Chem. Pharm. Bull. 1990, 38, 2201–2203. [Google Scholar] [CrossRef]
  168. de Carvalho, N.C.; Neves, S.P.; Dias, R.B.; Valverde, L.d.F.; Sales, C.B.S.; Rocha, C.A.G.; Soares, M.B.P.; dos Santos, E.R.; Oliveira, R.M.M.; Carlos, R.M.; et al. A novel ruthenium complex with xanthoxylin induces S-phase arrest and causes ERK1/2-mediated apoptosis in HepG2 cells through a p53-independent pathway. Cell Death Dis. 2018, 9, 79. [Google Scholar] [CrossRef]
  169. Wang, Y.-K.; Yang, X.-N.; Zhu, X.; Xiao, X.-R.; Yang, X.-W.; Qin, H.-B.; Gonzalez, F.J.; Li, F. Role of Metabolic Activation in Elemicin-Induced Cellular Toxicity. J. Agric. Food Chem. 2019, 67, 8243–8252. [Google Scholar] [CrossRef] [PubMed]
  170. Shulgin, A.T. Possible Implication of Myristicin as a Psychotropic Substance. Nature 1966, 210, 380–384. [Google Scholar] [CrossRef] [PubMed]
  171. Jirovetz, L.; Buchbauer, G.; Schmidt, E.; Denkova, Z.; Slavchev, A.; Stoyanova, A.; Geissler, M. Purity, Antimicrobial Activities and Olfactory Evaluations of 2-Phenylethanol and Some Derivatives. J. Essent. Oil Res. 2008, 20, 82–85. [Google Scholar] [CrossRef]
  172. Chowdary, G.V.; Ramesh, M.N.; Prapulla, S.G. Enzymic synthesis of isoamyl isovalerate using immobilized lipase from Rhizomucor miehei: A multivariate analysis. Process Biochem. 2000, 36, 331–339. [Google Scholar] [CrossRef]
  173. Birkett, M.A.; Campbell, C.A.M.; Chamberlain, K.; Guerrieri, E.; Hick, A.J.; Martin, J.L.; Matthes, M.; Napier, J.A.; Pettersson, J.; Pickett, J.A.; et al. New roles for cis-jasmone as an insect semiochemical and in plant defense. Proc. Natl. Acad. Sci. USA 2000, 97, 9329. [Google Scholar] [CrossRef]
  174. Tan, K.H.; Nishida, R. Methyl eugenol: Its occurrence, distribution, and role in nature, especially in relation to insect behavior and pollination. J. Insect Sci. 2012, 12, 56. [Google Scholar] [CrossRef]
  175. Masuyama, H.; Hiramatsu, Y.; Kunitomi, M.; Kudo, T.; MacDonald, P.N. Endocrine Disrupting Chemicals, Phthalic Acid and Nonylphenol, Activate Pregnane X Receptor-Mediated Transcription. Mol. Endocrinol. 2000, 14, 421–428. [Google Scholar] [CrossRef]
  176. Ahn, D.; Kwon, J.; Song, S.; Lee, J.; Yoon, S.; Chung, S.J. Methyl Syringate Stimulates Glucose Uptake by Inhibiting Protein Tyrosine Phosphatases Relevant to Insulin Resistance. Life 2023, 13, 1372. [Google Scholar] [CrossRef]
  177. Son, H.J.; Kim, M.J.; Park, J.-H.; Ishii, S.; Misaka, T.; Rhyu, M.-R. Methyl syringate, a low-molecular-weight phenolic ester, as an activator of the chemosensory ion channel TRPA1. Arch. Pharmacal Res. 2012, 35, 2211–2218. [Google Scholar] [CrossRef]
  178. Phuong, N.T.; Cuong, T.T.; Quang, D.N. Anti-inflammatory activity of methyl ferulate isolated from Stemona tuberosa Lour. Asian Pac. J. Trop. Med. 2014, 7, S327–S331. [Google Scholar] [CrossRef]
  179. Sultana, R. Ferulic acid ethyl ester as a potential therapy in neurodegenerative disorders. Biochim. Biophys. Acta 2012, 1822, 748–752. [Google Scholar] [CrossRef]
  180. Wu, Y.-X.; Wang, Y.-Y.; Gao, Z.-Q.; Chen, D.; Liu, G.; Wan, B.-B.; Jiang, F.-J.; Wei, M.-X.; Zuo, J.; Zhu, J.; et al. Ethyl ferulate protects against lipopolysaccharide-induced acute lung injury by activating AMPK/Nrf2 signaling pathway. Acta Pharmacol. Sin. 2021, 42, 2069–2081. [Google Scholar] [CrossRef]
  181. Cunha, F.V.M.; Coelho, A.G.; Azevedo, P.S.d.S.; da Silva, A.A.; Oliveira, F.d.A.; Nunes, L.C.C. Systematic review and technological prospection: Ethyl ferulate, a phenylpropanoid with antioxidant and neuroprotective actions. Expert Opin. Ther. Pat. 2019, 29, 73–83. [Google Scholar] [CrossRef]
  182. Fiorito, S.; Preziuso, F.; Sharifi-Rad, M.; Marchetti, L.; Epifano, F.; Genovese, S. Auraptene and umbelliprenin: A review on their latest literature acquisitions. Phytochem. Rev. 2020, 21, 317–326. [Google Scholar] [CrossRef]
  183. Guan, Z.; Hellman, J.; Schumacher, M. Contemporary views on inflammatory pain mechanisms: TRPing over innate and microglial pathways. F1000Research 2016, 5, 2425. [Google Scholar] [CrossRef] [PubMed]
  184. Cho, H.-J.; Jeong, S.-G.; Park, J.-E.; Han, J.-A.; Kang, H.-R.; Lee, D.; Song, M.J. Antiviral activity of angelicin against gammaherpesviruses. Antivir. Res. 2013, 100, 75–83. [Google Scholar] [CrossRef] [PubMed]
  185. Singh, L.; Bhatti, R. Signaling Pathways Involved in the Neuroprotective Effect of Osthole: Evidence and Mechanisms. Mol. Neurobiol. 2023, 1–19. [Google Scholar] [CrossRef] [PubMed]
  186. Jerris, P.J.; Smith, A.B. Synthesis and Configurational Assignment of Geiparvarin: A Novel Antitumor Agent. J. Org. Chem. 1981, 46, 577–585. [Google Scholar] [CrossRef]
Figure 1. Occurrence of species from the genus Geijera Schott [3].
Figure 1. Occurrence of species from the genus Geijera Schott [3].
Metabolites 14 00081 g001
Figure 2. Total plant compounds identified to date from each of the studied Geijera species.
Figure 2. Total plant compounds identified to date from each of the studied Geijera species.
Metabolites 14 00081 g002
Figure 3. Distribution of plant compounds identified to date within Geijera species. The number denotes the number of compounds of each class within the Geijera species.
Figure 3. Distribution of plant compounds identified to date within Geijera species. The number denotes the number of compounds of each class within the Geijera species.
Metabolites 14 00081 g003
Table 1. Geijera plant species and their synonyms.
Table 1. Geijera plant species and their synonyms.
Species (Accepted Name)Synonyms
Geijera balansae (Baill.) Schinz & GuillauminZanthoxylum balansae
Geijera cauliflora Baill.Dendrosma deplanchei Pancher & Sebert
Geijera deplanchei (Pancher & Sebert) Däniker
Geijera lateriflora Baill. ex Guillaumin
Geijera linearifolia (DC.) J.M.BlackGeijera parviflora var. crassifolia Benth.
Eriostemon linearifolius DC.
Geijera linearifolia Domin
Geijera parviflora Lindl.Geijera pendula Lindl.
Geijera parviflora var. parviflora Lindl.
Zanthoxylum australasicum A.Juss.
Geijera salicifolia SchottGeijera salicifolia var. augustifolia Maiden
Geijera salicifolia Schott var. salicifolia
Geijera salicifolia var. latifolia (Lindl.) Domin
Geijera salicifolia var. angustifolia Maiden & Betche
Geijera latifolia Lindl.
Geijera salicifolia var. typica Domin
Geijera floribunda Pancher ex Guillaumin
Geijera tartarea T.G.Hartley ex Munzinger & BruyNone
Table 6. Constituents identified in Geijera species according to their pharmacological activity type.
Table 6. Constituents identified in Geijera species according to their pharmacological activity type.
Type of ActivityNo. Compounds in GeijeraNo. Compounds in G. balansaeNo. Compounds in G. parvifloraNo. Compounds in G. salicifoliaNo. Compounds in G. linearifolia
Acetylcholinesterase inhibition7166-
Anti-cancer414322613
Anticonvulsant41332
Antifungal25516139
Antimicrobial459291912
Antioxidant20415112
Increase in membrane permeability3-23-
Monoamine oxidase B inhibition1-11-
Muscle relaxant52231
Osteogenic312--
Plant pest resistance/semiochemical/
insecticide
26121149
Psychoactive3-32-
Reduction in anxiety7-552
Reduction in
inflammation
38728176
Reduction in pain1218103
Table 7. Anti-inflammatory, analgesic, and antinociceptive compounds within the genus Geijera.
Table 7. Anti-inflammatory, analgesic, and antinociceptive compounds within the genus Geijera.
umbelliferone 1 Sxanthoxyletin 19 Bsabinene 52 P,Sβ-caryophyllene 83 P,S,L
6′-dehydromarmin 5 Pdictamine 25 Bα-phellandrene 53 P(E,E)-α-farnesene 86 P,S,L
(R)-6-O-(4-geranyloxy-2-hydroxy) cinnamoylmarmin 7 Pskimmianine 26 S,Bcitronellyl acetate 56 Lα-eudesmol 95 P,S,L
parvifloranine A 8 Pflindersine 30 P,Blinalool 61 P,S,Lβ-eudesmol 96 P,S,L
scoparone 11 PN-(acetoxymethyl) flindersine 35 Pα-terpineol 62 P,Sviridiflorol 98 P
suberosin 12 Phaplaphine 36 P,Bterpinen-4-ol 63 P,Scaryophyllene oxide 100 P,S,L
dehydrogeijerin 13 P,Smyrcene 44 P,S1,8 cineole 64 P,Sspathulenol 102 P,S,L
6-(methoxyl) geiparvarin 14 Pγ-terpinene 47 P,Scamphor 65 P,Scyclocolorenone 104 P
osthole 15 Pα-pinene 49 P,Sborneol 66 Sbrevifolin (xanthoxylin) 106 P,S,B
angelicin (isopsoralen) 16 Pβ-pinene 50 P,Sazulene 67 Pmethyl ferulate 116 B
luvangetin 18 Bp-cymene 55 P,Sα-caryophyllene (humulene) 82 Sethyl ferulate 117 B
(Sources: P—G. parviflora, S—G. salicifolia, L—G. linearifolia, B—G. balansae).
Table 8. Antimicrobial, antifungal, and antioxidant compounds within the genus Geijera.
Table 8. Antimicrobial, antifungal, and antioxidant compounds within the genus Geijera.
umbelliferone 1 Szanthobungeanine 33 Bnerol 59 Lguaiol 88 P,S
auraptene 3 P4-methoxy N-methyl-2-quinolone 37 Bgeraniol 60 Lelemol 89 P,S
scoparone 11 Phordenine 41 Blinalool 61 P,S,Lledol 91 P
osthole 15 P(E)-β-ocimene 42 P,S,Lα-terpineol 62 P,Sglobulol 92 P
angelicin (isopsoralen) 16 P(Z)-β-ocimene 43 P,S,Lterpinen-4-ol 63 P,Sepi-globulol 93 P
xanthyletine 17 Pmyrcene 44 P,S1,8 cineole 64 P,Sτ-cadinol 94 L
luvangetin 18 Bα-terpinene 46 P,Scamphor 65 P,Sα-eudesmol 95 P,S,L
xanthoxyletin 19 Bγ-terpinene 47 P,Sborneol 66 Sviridiflorol 98 P
11′-hexadecanoyl
anthranillic acid 20 P
terpinolene 48 P,Sviridiflorene (ledene) 71 Lspathulenol 102 P,S,L
9′-hexadecenoyl
anthranillic acid 21 P
camphene 51 Pgermacrene B 75 Scyclocolorenone 104 P
7′-hexadecanoyl
anthranillic acid 22 P
sabinene 52 P,Sgermacrene D 76 P,S,Lbrevifolin (xanthoxylin) 106 P,S,B
hexadecanoyl
anthranillic acid 24 P
α-phellandrene 53 Pα-caryophyllene
(humulene) 82 S
elemicin 107 P
dictamnine 25 Bβ-phellandrene 54 P,Sβ-caryophyllene 83 P,S,Lethyl ferulate 117 B
γ-fagarine 27 S,Bp-cymene 53 P,Saromadendrene 85 P,S,L
platydesmine 28 S,Bcitronellyl acetate 54 L(E,E)-α-farnesene 86 P,S,L
flindersine 30 P,Bgeranyl acetate 57 L(E,E)-farnesol 87 L
(Sources: P—G. parviflora, S—G. salicifolia, L—G. linearifolia, B—G. balansae).
Table 9. Neuroactive and psychoactive compounds within the genus Geijera.
Table 9. Neuroactive and psychoactive compounds within the genus Geijera.
Acetylcholinesterase
Inhibitors
Anxiolytics and SedativesMuscle Relaxants and
Anticonvulsants
Psychoactive Compounds
geijerin 10 P,Sosthole 15 Pxanthoxyletin 19 Bgeiparvarin 2 P,S
dehydrogeijerin 13 P,Smyrcene 44 P,Sgeibalansine 38 Bmyrcene 44 P,S
skimmianine 26 S,Blimonene 45 S(E)-β-ocimene 42 P,S,Lelemicin 107 P
α-terpinene 46 P,Sα-terpinene 46 P,S(Z)-β-ocimene 43 P,S,L
γ-terpinene 47 P,Slinalool 61 P,S,Lmyrcene 44 P,S
β-phellandrene 54 P,Sborneol 66 Sα-terpineol 62 P,S
elemicin 107 Pβ-eudesmol 96 P,S,Lborneol 66 S
τ-cadinol 94 L
brevifolin (xanthoxylin) 106 P,S
(Sources: P—G. parviflora, S—G. salicifolia, L—G. linearifolia, B—G. balansae).
Table 10. Anti-cancer compounds within the genus Geijera.
Table 10. Anti-cancer compounds within the genus Geijera.
umbelliferone 1 Sdictamnine 25 Bp-cymene 55 P,Sβ-caryophyllene 83 P,S,L
geiparvarin 2 P,Sskimmianine 26 S, Bcitronellyl acetate 56 L(E,E)-α-farnesene 86 P,S,L
auraptene 3 Phaplaphine 36 P,Bgeranyl acetate 57 Lguaiol 88 P,S
6′dehydromarmin 5 P(E)-β-ocimene 42 P,S,Lα-terpineol 62 P,Sα-eudesmol 95 P,S,L
2′,3′-dihydrogeiparvarin 6 P,S(Z)-β-ocimene 43 P,S,Lterpinen-4-ol 63 P,Sβ-eudesmol 96 P,S,L
(R)-6-O-(4-geranyloxy-2-hydroxy) cinnamoylmarmin 7 Pmyrcene 44 P,S
camphor 65 P,Sγ-eudesmol 97 P,S,L
scoparone 11 Plimonene 45 S
germacrene D 76 P,S,Lcaryophyllene oxide 100 P,S,L
6-(methoxyl) geiparvarin 14 Pα-pinene 49 P,Sδ-cadinene 79 Pspathulenol 102 P,S,L
osthole 15 Pβ-pinene 50 P,Sβ-elemene 80 P,S,Leremophilone 103 P
angelicin (isopsoralen) 16 Pα-phellandrene 53 Pα-caryophyllene (humulene) 82 Sβ-sitosterol 105 S
xanthoxyletin 19 B
(Sources: P—G. parviflora, S—G. salicifolia, L—G. linearifolia, B—G. balansae).
Table 11. Antifeedant, oviposition deterrent, insecticidal, and semiochemical compounds within the genus Geijera.
Table 11. Antifeedant, oviposition deterrent, insecticidal, and semiochemical compounds within the genus Geijera.
InsecticidesSemiochemicalsAntifeedantsOviposition Deterrents
terpinolene 48 P,S(E)-β-ocimene 42 P,S,Lumbelliferone 1 Spregeijerene 68 S
α-phellandrene 53 P(Z)-β-ocimene 43 P,S,Lhordenine 41 Bgeijerene 70 S,P
citronellyl acetate 56 Lα-santalene 84 Ppregeijerene 68 S
α-terpineol 62 P,S(E,E)-α-farnesene 86 P,S,Lgeijerene 70 S,P
camphor 65 P,Spalustrol 90 Lα-bergamotene 78 P
germacrene D 73 P,S,Lepi-globulol 93 Peremophilone 103 P
bicyclogermacrene 77 P,S,Lβ-eudesmol 96 P,S,Lcyclocolorenone 104 P
δ-cadinene 79 P(E,E)-farnesal 99 L
γ-elemene 81 P,Scis-jasmone 111 P
guaiol 88 P,Smethyl eugenol 112 P
β-eudesmol 96 P,S,L
eremophilone 103 P
(Sources: P—G. parviflora, S—G. salicifolia, L—G. linearifolia, B—G. balansae).
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Dugan, D.; Bell, R.J.; Brkljača, R.; Rix, C.; Urban, S. A Review of the Ethnobotanical Use, Chemistry and Pharmacological Activities of Constituents Derived from the Plant Genus Geijera (Rutaceae). Metabolites 2024, 14, 81. https://doi.org/10.3390/metabo14020081

AMA Style

Dugan D, Bell RJ, Brkljača R, Rix C, Urban S. A Review of the Ethnobotanical Use, Chemistry and Pharmacological Activities of Constituents Derived from the Plant Genus Geijera (Rutaceae). Metabolites. 2024; 14(2):81. https://doi.org/10.3390/metabo14020081

Chicago/Turabian Style

Dugan, Deepika, Rachael J. Bell, Robert Brkljača, Colin Rix, and Sylvia Urban. 2024. "A Review of the Ethnobotanical Use, Chemistry and Pharmacological Activities of Constituents Derived from the Plant Genus Geijera (Rutaceae)" Metabolites 14, no. 2: 81. https://doi.org/10.3390/metabo14020081

APA Style

Dugan, D., Bell, R. J., Brkljača, R., Rix, C., & Urban, S. (2024). A Review of the Ethnobotanical Use, Chemistry and Pharmacological Activities of Constituents Derived from the Plant Genus Geijera (Rutaceae). Metabolites, 14(2), 81. https://doi.org/10.3390/metabo14020081

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop